Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 206

Zeitschriftenartikel

Weiss, L.; Heinrich, K.; Zhang, D.; Dorman, K.; Rühlmann, K.; Hasselmann, K.; Klauschen, F.; Kumbrink, J.; Jung, A.; Rudelius, M.; Mock, A.; Ormanns, Steffen ORCID logoORCID: https://orcid.org/0000-0002-0754-9034; Kunz, W. G.; Roessler, D.; Beyer, G.; Corradini, S.; Heinzerling, L.; Haas, M.; Bergwelt-Baildon, Michael von ORCID logoORCID: https://orcid.org/0000-0002-1952-052X; Boeck, S.; Heinemann, Volker ORCID logoORCID: https://orcid.org/0000-0002-1349-3321 und Westphalen, C. B. ORCID logoORCID: https://orcid.org/0000-0002-5310-3754 (2023): Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective. In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 11: S. 8225-8234 [PDF, 623kB]

Issels, Rolf D. ORCID logoORCID: https://orcid.org/0000-0002-3494-6561; Böck, Stefan; Pelzer, Uwe; Mansmann, Ulrich ORCID logoORCID: https://orcid.org/0000-0002-9955-8906; Ghadjar, Pirus; Lindner, Lars H. ORCID logoORCID: https://orcid.org/0000-0003-3708-8264; Albertsmeier, Markus ORCID logoORCID: https://orcid.org/0000-0002-5028-5062; Angele, Martin K.; Schmidt, Michael ORCID logoORCID: https://orcid.org/0000-0001-5898-9323; Xu, Yujun ORCID logoORCID: https://orcid.org/0000-0002-8487-7584; Bahra, Marcus; Pratschke, Johann; Schoenberg, Michael; Thasler, Wolfgang E.; Salat, Christoph; Stoetzer, Oliver J.; Knoefel, Wolfram T.; Graf, Dirk; Wessalowski, Rüdiger; Keitel-Anselmino, Verena; Koenigsrainer, Alfred; Bitzer, Michael ORCID logoORCID: https://orcid.org/0000-0002-4463-8263; Zips, Daniel; Bamberg, Michael; Fietkau, Rainer; Ott, Oliver; Kawecki, Maciej ORCID logoORCID: https://orcid.org/0000-0001-7858-6214; Wyrwicz, Lucjan; Rutkowski, Piotr; Rentsch, Markus; Ababei, Juliana; Reichardt, Peter; Rigamonti, Marco; Weber, Bernhard; Abdel-Rahman, Sultan; Tschoep–Lechner, Katharina; Jauch, Karl-Walter; Bruns, Christiane J.; Oettle, Helmut; Bergwelt-Baildon, Michael von; Heinemann, Volker ORCID logoORCID: https://orcid.org/0000-0002-1349-3321 und Werner, Jens (2023): Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial. In: European Journal of Cancer (EJC), Bd. 181: S. 155-165

Guenther, Michael; Surendran, Sai Agash; Haas, Michael; Heinemann, Volker; Bergwelt-Baildon, Michael von ORCID logoORCID: https://orcid.org/0000-0002-1952-052X; Engel, Jutta; Werner, Jens; Boeck, Stefan ORCID logoORCID: https://orcid.org/0000-0002-1922-2127 und Ormanns, Steffen ORCID logoORCID: https://orcid.org/0000-0002-0754-9034 (2023): TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer. In: British Journal of Cancer, Bd. 129: S. 175-182 [PDF, 1MB]

Kasprzak, Julia ORCID logoORCID: https://orcid.org/0000-0002-9511-606X; Frey, Simon; Oetlinger, Hermann; Westphalen, Christoph Benedikt; Erickson, Nicole; Heinemann, Volker und Nasseh, Daniel (2023): Swapping data: A pragmatic approach for enabling academic-industrial partnerships. In: Digital Health, Bd. 9 [PDF, 923kB]

Pretzsch, Elise; Heinemann, Volker; Stintzing, Sebastian; Bender, Andreas; Chen, Shuo; Holch, Julian Walter; Hofmann, Felix Oliver; Ren, Haoyu; Bösch, Florian; Küchenhoff, Helmut; Werner, Jens und Angele, Martin Konrad (14. November 2022): EMT-Related Genes Have No Prognostic Relevance in Metastatic Colorectal Cancer as Opposed to Stage II/III: Analysis of the Randomised, Phase III Trial FIRE-3 (AIO KRK 0306; FIRE-3). In: Cancers, Bd. 14, Nr. 22 [PDF, 650kB]

Guenther, Michael; Boeck, Stefan; Heinemann, Volker; Werner, Jens; Engel, Jutta und Ormanns, Steffen ORCID logoORCID: https://orcid.org/0000-0002-0754-9034 (2022): The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer. In: International Journal of Cancer, Bd. 151, Nr. 6: S. 914-919 [PDF, 443kB]

Guenther, Michael; Gil, Lina; Surendran, Sai Agash; Palm, Melanie Alexandra; Heinemann, Volker ORCID logoORCID: https://orcid.org/0000-0002-1349-3321; Bergwelt-Baildon, Michael von ORCID logoORCID: https://orcid.org/0000-0002-1952-052X; Mayerle, Julia; Engel, Jutta; Werner, Jens; Boeck, Stefan und Ormanns, Steffen ORCID logoORCID: https://orcid.org/0000-0002-0754-9034 (2022): Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic Cancer. In: JNCI Cancer Spectrum, Bd. 6, Nr. 3, pkac039 [PDF, 555kB]

Hofmann, Felix O. ORCID logoORCID: https://orcid.org/0000-0002-6913-2429; Heinemann, Volker; D'Anastasi, Melvin; Gesenhues, Alena B.; Hesse, Nina; Weikersthal, Ludwig Fischer von; Decker, Thomas; Kiani, Alexander; Moehler, Markus; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Modest, Dominik P.; Stintzing, Sebastian und Holch, Julian W. (2022): Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3/AIO KRK-0306. In: European Radiology, Bd. 33, Nr. 2: S. 1174-1184 [PDF, 2MB]

Dorman, Klara; Gerckens, Miriam; Kruger, Stephan; Krueger, Kimberly; Mayer, Zsuzsanna; Rupp, Alexander; Zhang, Danmei; Weiss, Lena; Westphalen, C. Benedikt; Haas, Michael; Guenther, Michael; Ormanns, Steffen; Klawonn, Frank; Werner, Jens; Bergwelt-Baildon, Michael von; Heinemann, Volker; Böck, Stefan und Holdenrieder, Stefan (2022): Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-gamma, TNF-alpha and PD-1/PD-L1 in comparison to established serum tumor markers. In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 6: S. 2463-2474 [PDF, 1MB]

Heinrich, Kathrin; Miller-Phillips, Lisa; Ziemann, Frank; Hasselmann, Korbinian; Rühlmann, Katharina; Flach, Madeleine; Biro, Dorottya; Bergwelt-Baildon, Michael von; Holch, Julian; Herold, Tobias; Baumgarten, Louisa von; Greif, Philip A. ORCID logoORCID: https://orcid.org/0000-0002-3744-7936; Jeremias, Irmela; Wuerstlein, Rachel; Casuscelli, Jozefina; Spitzweg, Christine; Seidensticker, Max; Renz, Bernhard; Corradini, Stefanie; Baumeister, Philipp; Goni, Elisabetta; Tufman, Amanda; Jung, Andreas; Kumbrink, Jörg; Kirchner, Thomas; Klauschen, Frederick; Metzeler, Klaus H.; Heinemann, Volker und Westphalen, C. Benedikt ORCID logoORCID: https://orcid.org/0000-0002-5310-3754 (2022): Lessons learned: the first consecutive 1000 patients of the CCCMunich(LMU) Molecular Tumor Board. In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 5: S. 1905-1915 [PDF, 728kB]

Fey, Theres; Erickson, Nicole ORCID logoORCID: https://orcid.org/0000-0002-0473-7689; Stahler, Arndt; Muenchhoff, Maximilian; Keppler, Oliver T.; Rühlmann, Katharina; Krauss-Pfeiffer, Gabriele; Steinberg, Hannah; Graf, Alexander; Krebs, Stefan; Blum, Helmut; Khatamzas, Elham; Seynstahl, Sarah; Casuscelli, Jozefina; Markwardt, Daniel; Forstpointner, Roswitha; Schinkoethe, Timo; Bergwelt-Baildon, Michael von und Heinemann, Volker (2022): Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV. In: Medical Oncology, Bd. 39, Nr. 6 [PDF, 678kB]

Tamalunas, Alexander ORCID logoORCID: https://orcid.org/0000-0002-4659-2262; Schott, Melanie ORCID logoORCID: https://orcid.org/0000-0002-6477-5636; Ivanova, Troya ORCID logoORCID: https://orcid.org/0000-0002-1073-4150; Rodler, Severin ORCID logoORCID: https://orcid.org/0000-0002-7600-6535; Heinemann, Volker ORCID logoORCID: https://orcid.org/0000-0002-1349-3321; Stief, Christian G. ORCID logoORCID: https://orcid.org/0000-0003-3291-9460 und Casuscelli, Jozefina ORCID logoORCID: https://orcid.org/0000-0002-9899-1986 (2022): Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient population. In: Infection, Bd. 50, Nr. 5: S. 1131-1137 [PDF, 909kB]

Fischer, Laura E. ORCID logoORCID: https://orcid.org/0000-0001-8752-5827; Stintzing, Sebastian; Weikersthal, Ludwig Fischer von; Modest, Dominik P.; Decker, Thomas; Kiani, Alexander ORCID logoORCID: https://orcid.org/0000-0002-2494-4087; Kaiser, Florian; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Giessen-Jung, Clemens; Uhlig, Jens; Peuser, Bettina; Denzlinger, Claudio; Stahler, Arndt; Weiss, Lena; Heinrich, Kathrin; Held, Swantje; Jung, Andreas; Kirchner, Thomas und Heinemann, Volker (2022): Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3. In: British Journal of Cancer, Bd. 127, Nr. 5: S. 836-843 [PDF, 788kB]

Kumbrink, Jorg; Bohlmann, Lisa; Mamlouk, Soulafa; Redmer, Torben; Peilstocker, Daniela; Li, Pan; Lorenzen, Sylvie; Alguel, Hana; Kasper, Stefan; Hempel, Dirk; Kaiser, Florian; Michl, Marlies; Bartsch, Harald; Neumann, Jens; Klauschen, Frederick; Bergwelt-Baildon, Michael von; Modest, Dominik Paul; Stahler, Arndt; Stintzing, Sebastian; Jung, Andreas; Kirchner, Thomas; Schäfer, Reinhold; Heinemann, Volker und Holch, Julian W. (2022): Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL. In: Cancers, Bd. 14, Nr. 15 [PDF, 4MB]

Torlot, Lucien; Jarzab, Anna; Albert, Johanna; Pok-Udvari, Agnes; Stahler, Arndt; Holch, Julian Walter; Gerlinger, Marco; Heinemann, Volker; Klauschen, Frederick; Kirchner, Thomas; Kumbrink, Jörg; Küster, Bernhard und Jung, Andreas ORCID logoORCID: https://orcid.org/0000-0001-5270-9108 (2022): Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance. In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 2: S. 669-682 [PDF, 2MB]

Pichler, Theresia; Marten-Mittag, Birgitt; Hermelink, Kerstin; Telzerow, Eva; Frank, Tamara; Ackermann, Ulrike; Belka, Claus; Combs, Stephanie E.; Gratzke, Christian; Gschwend, Jürgen; Harbeck, Nadia; Heinemann, Volker; Herkommer, Kathleen; Kiechle, Marion; Mahner, Sven; Pigorsch, Steffi; Rauch, Josefine; Stief, Christian; Mumm, Friederike; Heussner, Pia; Herschbach, Peter und Dinkel, Andreas (2021): Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics. In: Psycho-Oncology, Bd. 31, Nr. 5: S. 770-778

Sultova, Elena; Westphalen, C. Benedikt; Jung, Andreas; Kumbrink, Joerg; Kirchner, Thomas; Mayr, Doris; Rudelius, Martina; Ormanns, Steffen; Heinemann, Volker; Metzeler, Klaus H.; Greif, Philipp A.; Burges, Alexander; Trillsch, Fabian; Mahner, Sven; Harbeck, Nadia und Wuerstlein, Rachel (2021): NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU. In: Archives of gynecology and obstetrics, Bd. 303, Nr. 5: S. 1331-1345 [PDF, 1MB]

Vangala, Deepak; Ladigan, Swetlana; Liffers, Sven-Thorsten; Noseir, Soha; Maghnouj, Abdelouahid; Götze, Tina-Maria; Verdoodt, Berlinda; Klein-Scory, Susanne; Godfrey, Laura; Zowada, Martina K.; Huerta, Mario; Edelstein, Daniel L.; Villarreal, Jaime Martinez de; Marqués, Miriam; Kumbrink, Jörg; Jung, Andreas; Schiergens, Tobias S.; Werner, Jens; Heinemann, Volker; Stintzing, Sebastian; Lindoerfer, Doris ORCID logoORCID: https://orcid.org/0000-0003-3078-0856; Mansmann, Ulrich; Pohl, Michael; Teschendorf, Christian; Bernhardt, Christiane; Wolters, Heiner; Stern, Josef; Usta, Selami; Viebahn, Richard; Admard, Jacob; Casadei, Nicolas; Fröhling, Stefan; Ball, Claudia R.; Siveke, Jens T.; Glimm, Hanno; Tannapfel, Andrea; Schmiegel, Wolff und Hahn, Stephan A. (2021): Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models. In: Genome Medicine, Bd. 13, Nr. 116 [PDF, 4MB]

Arai, Hiroyuki; Cao, Shu; Battaglin, Francesca; Wang, Jingyuan; Kawanishi, Natsuko; Tokunaga, Ryuma; Loupakis, Fotios; Stintzing, Sebastian; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Salhia, Bodour; Mumenthaler, Shannon M.; Cremolini, Chiara; Heinemann, Volker; Falcone, Alfredo; Millstein, Joshua und Lenz, Heinz-Josef (2021): RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC. In: Molecular Cancer Therapeutics, Bd. 20, Nr. 6: S. 1153-1160

Arai, Hiroyuki; Millstein, Joshua; Loupakis, Fotios; Stintzing, Sebastian; Wang, Jingyuan; Battaglin, Francesca; Kawanishi, Natsuko; Jayachandran, Priya; Soni, Shivani; Zhang, Wu; Mumenthaler, Shannon M.; Cremolini, Chiara; Heinemann, Volker; Falcone, Alfredo und Lenz, Heinz-Josef (2021): Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancer. In: European Journal of Cancer, Bd. 150: S. 133-142

Cohen, Romain; Liu, Heshan; Fiskum, Jack; Adams, Richard; Chibaudel, Benoist; Maughan, Timothy S.; Cutsem, Eric van; Venook, Alan; Douillard, Jean-Yves; Heinemann, Volker; Punt, Cornelis Ja; Falcone, Alfredo; Bokemeyer, Carsten; Kaplan, Richard; Lenz, Heinz-Josef; Koopman, Miriam; Yoshino, Takayuki; Zalcberg, John; Grothey, Alex; Gramont, Aimery de; Shi, Qian und Andre, Thierry (2021): BRAF(V600E) Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database. In: Jnci-Journal of the National Cancer Institute, Bd. 113, Nr. 10, djab042: S. 1386-1395

Gebauer, Leonie; Moltz, Jan H.; Mühlberg, Alexander; Holch, Julian W.; Huber, Thomas; Enke, Johanna; Jäger, Nils; Haas, Michael; Kruger, Stephan; Boeck, Stefan; Sühling, Michael; Katzmann, Alexander; Hahn, Horst; Kunz, Wolfgang G.; Heinemann, Volker; Noerenberg, Dominik und Maurus, Stefan (2021): Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer. In: Cancers, Bd. 13, Nr. 22, 5732

Heinrich, Kathrin; Modest, Dominik P.; Ricard, Ingrid; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Graeven, Ullrich; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Giessen-Jung, Clemens; Stahler, Arndt; Michl, Marlies; Held, Swantje; Jung, Andreas; Kirchner, Thomas; Stintzing, Sebastian und Heinemann, Volker (2021): Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110). In: European Journal of Cancer, Bd. 147: S. 128-139

Kunzmann, Volker; Siveke, Jens T.; Alguel, Hana; Goekkurt, Eray; Siegler, Gabriele; Martens, Uwe; Waldschmidt, Dirk; Pelzer, Uwe; Fuchs, Martin; Kullmann, Frank; Boeck, Stefan; Ettrich, Thomas J.; Held, Swantje; Keller, Ralph; Klein, Ingo; Germer, Christoph-Thomas; Stein, Hubert; Friess, Helmut; Bahra, Marcus; Jakobs, Ralf; Hartlapp, Ingo und Heinemann, Volker (2021): Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial. In: Lancet Gastroenterology & Hepatology, Bd. 6, Nr. 2: S. 128-138

Liu, Lian; Erickson, Nicole Tonya; Ricard, Ingrid; Weikersthal, Ludwig Fischer von; Lerch, Markus M.; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Hoeffkes, Heinz-Gert; Moehler, Markus; Gesenhues, Alena Britta; Theurich, Sebastian; Michl, Marlies; Modest, Dominik P.; Alguel, Hana; Stintzing, Sebastian; Heinemann, Volker und Holch, Julian W. (2021): Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306). In: International Journal of Cancer, Bd. 150, Nr. 1: S. 112-123

Moehler, Markus; Folprecht, Gunnar; Heinemann, Volker; Holch, Julian Walter; Maderer, Annett; Kasper, Stefan; Hegewisch-Becker, Susanna; Schroeder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Voehringer, Matthias; Oellinger, Robert; Lordick, Florian; Geissler, Michael; Schulz-Abelius, Armin; Linz, Bernhard; Bernhard, Helga; Paul, Andreas; Schmidtmann, Irene; Potthoff, Karin und Schimanski, Carl Christoph (2021): Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3). In: International Journal of Cancer, Bd. 150, Nr. 8: S. 1341-1349

Naseem, Madiha; Cao, Shu; Yang, Dongyun; Millstein, Joshua; Puccini, Alberto; Loupakis, Fotios; Stintzing, Sebastian; Cremolini, Chiara; Tokunaga, Ryuma; Battaglin, Francesca; Soni, Shivani; Berger, Martin D.; Barzi, Afsaneh; Zhang, Wu; Falcone, Alfredo; Heinemann, Volker und Lenz, Heinz-Josef (2021): Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients. In: Scientific Reports, Bd. 11, Nr. 1, 12191

Rodler, Severin; Buchner, Alexander; Stief, Christian G.; Heinemann, Volker; Staehler, Michael und Casuscelli, Jozefina (2021): Patients' Perspective on Digital Technologies in Advanced Genitourinary Cancers. In: Clinical Genitourinary Cancer, Bd. 19, Nr. 1: 76-

Rodler, Severin; Jung, Andreas; Greif, Philipp A.; Ruehlmann, Katharina; Apfelbeck, Maria; Tamalunas, Alexander; Kretschmer, Alexander; Schulz, Gerald B.; Szabados, Bernadett; Stief, Christian; Heinemann, Volker; Westphalen, Christoph B. und Casuscelli, Jozefina (2021): Routine application of next-generation sequencing testing in uro-oncology-Are we ready for the next step of personalised medicine? In: European Journal of Cancer, Bd. 146: S. 1-10

Stahler, Arndt; Heinemann, Volker; Schuster, Veronika; Heinrich, Kathrin; Kurreck, Annika; Giessen-Jung, Clemens; Weikersthal, Ludwig Fischer von; Kaiser, Florian; Decker, Thomas; Held, Swantje; Graeven, Ullrich; Schwaner, Ingo; Denzlinger, Claudio; Schenk, Michael; Neumann, Jens; Kirchner, Thomas; Jung, Andreas; Kumbrink, Jorg; Stintzing, Sebastian und Modest, Dominik P. (2021): Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial). In: European Journal of Cancer, Bd. 157: S. 71-80

Sultova, Elena; Westphalen, C. Benedikt; Jung, Andreas; Kumbrink, Jörg; Kirchner, Thomas; Mayr, Doris; Rudelius, Martina; Ormanns, Steffen; Heinemann, Volker; Metzeler, Klaus H.; Greif, Philipp A.; Hester, Anna; Mahner, Sven; Harbeck, Nadia und Würstlein, Rachel (2021): Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting. In: Diagnostics, Bd. 11, Nr. 4, 733

Vangala, Deepak; Ladigan, Swetlana; Liffers, Sven T.; Noseir, Soha; Maghnouj, Abdelouahid; Gotze, Tina-Maria; Verdoodt, Berlinda; Klein-Scory, Susanne; Godfrey, Laura; Zowada, Martina K.; Huerta, Mario; Edelstein, Daniel L.; de Villarreal, Jaime Martinez; Marques, Miriam; Kumbrink, Jorg; Jung, Andreas; Schiergens, Tobias; Werner, Jens; Heinemann, Volker; Stintzing, Sebastian; Lindoerfer, Doris; Mansmann, Ulrich; Pohl, Michael; Teschendorf, Christian; Bernhardt, Christiane; Wolters, Heiner; Stern, Josef; Usta, Selami; Viebahn, Richard; Admard, Jacob; Casadei, Nicolas; Frohling, Stefan; Ball, Claudia R.; Siveke, Jens T.; Glimm, Hanno; Tannapfel, Andrea; Schmiegel, Wolff und Hahn, Stephan A. (2021): Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models. In: Genome Medicine, Bd. 13, Nr. 1, 116

Wick, Antje; Baehr, Oliver; Schuler, Martin; Rohrberg, Kristoffer; Chawla, Sant P.; Janku, Filip; Schiff, David; Heinemann, Volker; Narita, Yoshitaka; Lenz, Heinz-Josef; Ikeda, Masafumi; Ando, Yuichi; Wick, Wolfgang; Steinbach, Joachim P.; Burger, Michael C.; Wenger, Katharina; Lassen, Ulrik; Sankhala, Kamalesh K.; Roggia, Cristiana; Genvresse, Isabelle; Munhoz, Catya; Rentzsch, Christine; Reschke, Susanne; Langer, Simon; Wagner, Markus; Kaulfuss, Stefan; Cai, Charles; Lagkadinou, Eleni; Jeffers, Michael; Pena, Carol und Tabatabai, Ghazaleh (2021): Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors. In: Clinical Cancer Research, Bd. 27, Nr. 10: S. 2723-2733

Yin, Jun; Cohen, Romain; Jin, Zhaohui; Liu, Heshan; Pederson, Levi; Adams, Richard; Grothey, Axel; Maughan, Timothy S.; Venook, Alan; Cutsem, Eric van; Punt, Cornelis; Koopman, Miriam; Falcone, Alfredo; Tebbutt, Niall C.; Seymour, Matthew T.; Bokemeyer, Carsten; Rubio, Eduardo Diaz; Kaplan, Richard; Heinemann, Volker; Chibaudel, Benoist; Yoshino, Takayuki; Zalcberg, John; Andre, Thierry; Gramont, Aimery de; Shi, Qian und Lenz, Heinz-Josef (2021): Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer. In: Jnci-Journal of the National Cancer Institute, Bd. 113, Nr. 12: S. 1705-1713

Yin, Jun; Dawood, Shaheenah; Cohen, Romain; Meyers, Jeff; Zalcberg, John; Yoshino, Takayuki; Seymour, Matthew; Maughan, Tim; Saltz, Leonard; Cutsem, Eric van; Venook, Alan; Schmoll, Hans-Joachim; Goldberg, Richard; Hoff, Paulo; Hecht, J. Randolph; Hurwitz, Herbert; Punt, Cornelis; Diaz Rubio, Eduard; Koopman, Miriam; Cremolini, Chiara; Heinemann, Volker; Tournigard, Christophe; Bokemeyer, Carsten; Fuchs, Charles; Tebbutt, Niall; Souglakos, John; Doulliard, Jean-Yves; Kabbinavar, Fairooz; Chibaudel, Benoist; Gramont, Aimery de; Shi, Qian; Grothey, Axel und Adams, Richard (2021): Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis. In: Therapeutic Advances in Medical Oncology, Bd. 13, 17588359211020547

Michl, Marlies; Taverna, F.; Kumbrink, Jörg; Schiergens, Tobias S.; Heinemann, Volker; Engel, Jutta; Kirchner, Thomas und Neumann, Jens (9. Dezember 2020): Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer. In: Virchows Archiv, Bd. 478: S. 695-705 [PDF, 1MB]

Thurmaier, Johannes; Heinemann, Volker; Engel, Jutta; Schubert‐Fritschle, Gabriele; Wiedemann, Max; Nüssler, Natascha C.; Ruppert, Reinhard; Kleeff, Jörg; Schepp, Wolfgang; Löhe, Florian; Karthaus, Meinolf; Neumann, Jens; Kumbrink, Jörg; Taverna, Francesco; Stahler, Arndt ORCID logoORCID: https://orcid.org/0000-0003-1041-0137; Heinrich, Kathrin; Westphalen, Christoph Benedikt; Holch, Julian W.; Kirchner, Thomas und Michl, Marlies (28. Oktober 2020): Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival. In: International Journal of Cancer, Bd. 148, Nr. 8: S. 1919-1927 [PDF, 619kB]

Froelich, Matthias F.; Petersen, Elina L.; Heinemann, Volker; Noerenberg, Dominik; Hesse, Nina; Gesenhues, Alena B.; Modest, Dominik P.; Sommer, Wieland H.; Hofmann, Felix O.; Stintzing, Sebastian und Holch, Julian W. (2020): Impact of Size and Location of Metastases on Early Tumor Shrinkage and Depth of Response in Patients With Metastatic Colorectal Cancer: Subgroup Findings of the Randomized, Open-Label Phase 3 Trial FIRE-3/AIO KRK-0306. In: Clinical Colorectal Cancer, Bd. 19, Nr. 4: S. 291-300

Stahler, Arndt ORCID logoORCID: https://orcid.org/0000-0003-1041-0137; Heinemann, Volker; Ricard, Ingrid; Einem, Jobst C. von; Giessen-Jung, Clemens; Westphalen, Christoph Benedikt; Michl, Marlies; Heinrich, Kathrin; Miller-Phillips, Lisa; Jelas, Ivan; Stintzing, Sebastian und Modest, Dominik Paul (2020): Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials. In: Journal of cancer research and clinical oncology, Bd. 146, Nr. 8: S. 2077-2087 [PDF, 1MB]

Ettrich, Thomas J.; Perkhofer, Lukas; Decker, Thomas; Hofheinz, Ralf-Dieter; Heinemann, Volker; Hoffmann, Thomas; Hebart, Holger F.; Herrmann, Thomas; Hannig, Carla V.; Buechner-Steudel, Petra; Guthle, Melanie; Hermann, Patrick C.; Berger, Andreas W. und Seufferlein, Thomas (2020): Nintedanib plusmFOLFOX6as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phaseII TRICC-Cstudy (AIO-KRK-0111). In: International Journal of Cancer, Bd. 148, Nr. 6: S. 1428-1437

Muehlberg, Alexander; Holch, Julian W.; Heinemann, Volker; Huber, Thomas; Moltz, Jan; Maurus, Stefan; Jaeger, Nils; Liu, Lian; Froelich, Matthias F.; Katzmann, Alexander; Gresser, Eva; Taubmann, Oliver; Suehling, Michael und Noerenberg, Dominik (2020): The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer. In: European Radiology, Bd. 31, Nr. 2: S. 834-846

Pichler, Theresia; Rohrmoser, Amy; Letsch, Anne; Westphalen, C. Benedikt; Keilholz, Ulrich; Heinemann, Volker; Lamping, Mario; Jost, Philipp J.; Riedmann, Kristina; Herschbach, Peter und Goerling, Ute (2020): Information, communication, and cancer patients' trust in the physician: what challenges do we have to face in an era of precision cancer medicine? In: Supportive Care in Cancer, Bd. 29, Nr. 4: S. 2171-2178

Fischer, Laura Elisabeth und Heinemann, Volker (2020): Systemtherapie des metastasierten Analkarzinoms. In: Onkologe, Bd. 26, Nr. 4: S. 356-361

Ganschow, Petra; Hofmann, Lena; Stintzing, Sebastian; Heinemann, Volker; Angele, Martin; Werner, Jens und Schulz, Christoph (2020): Operative Results and Perioperative Morbidity After Intensified Neoadjuvant Chemotherapy with FLOT for Gastroesophageal Adenocarcinoma Impact of Intensified Neoadjuvant Treatment. In: Journal of Gastrointestinal Surgery, Bd. 25, Nr. 1: S. 58-66

Schimanski, Carl Christoph; Kasper, Stefan; Hegewisch-Becker, Susanna; Schroeder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Voehringer, Matthias; Oellinger, Robert; Lordick, Florian; Heinemann, Volker; Geissler, Michael; Schulz-Abelius, Armin; Bernhard, Helga; Schoen, Michael R.; Greil, Richard; Galle, Peter; Lang, Hauke; Schmidtmann, Irene und Moehler, Markus (2020): Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC). In: Oncoimmunology, Bd. 9, Nr. 1, 1806680

Berger, Martin D.; Ning, Yan; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Zhang, Wu; Yang, Dongyun; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Hanna, Diana L.; Soni, Shivani; Puccini, Alberto; Tokunaga, Ryuma; Naseem, Madiha; Battaglin, Francesca; Cremolini, Chiara; Falcone, Alfredo; Loupakis, Fotios und Lenz, Heinz-Josef (2020): A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials. In: European Journal of Cancer, Bd. 131: S. 89-97

Rodler, Severin; Apfelbeck, Maria; Stief, Christian; Heinemann, Volker und Casuscelli, Jozefina (2020): Lessons from the coronavirus disease 2019 pandemic: Will virtual patient management reshape uro-oncology in Germany? In: European Journal of Cancer, Bd. 132: S. 136-140

Kurreck, Annika; Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Graeven, Ullrich; Schwaner, Ingo; Stahler, Arndt; Heinrich, Kathrin; Jung, Andreas; Held, Swantje; von Einem, Jobst C.; Stintzing, Sebastian; Giessen-Jung, Clemens und Modest, Dominik P. (2020): Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study). In: European Journal of Cancer, Bd. 137: S. 81-92

Stahler, Arndt; Stintzing, Sebastian; Einem, Jobst C. von; Westphalen, Christoph B.; Heinrich, Kathrin; Kraemer, Nicole; Michl, Marlies; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Moehler, Markus; Kaiser, Florian; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker (2020): Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial. In: European Journal of Cancer, Bd. 137: S. 250-259

Rodler, Severin; Apfelbeck, Maria; Schulz, Gerald Bastian; Ivanova, Troya; Buchner, Alexander; Staehler, Michael; Heinemann, Volker; Stief, Christian und Casuscelli, Jozefina (2020): Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver? In: European Urology Focus, Bd. 6, Nr. 5: S. 1097-1103

Guenther, Michael; Haas, Michael; Heinemann, Volker; Kruger, Stephan; Westphalen, Christoph Benedikt; Bergwelt-Baildon, Michael von; Mayerle, Julia; Werner, Jens; Kirchner, Thomas; Boeck, Stefan und Ormanns, Steffen (2020): Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study. In: British Journal of Cancer, Bd. 123, Nr. 9: S. 1370-1376

Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Al-Batran, Salah-Edin; Heintges, Tobias; Lerchenmüller, Christoph; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Moehler, Markus; Scheithauer, Werner; Held, Swantje; Miller-Phillips, Lisa; Modest, Dominik Paul; Jung, Andreas; Kirchner, Thomas und Stintzing, Sebastian (2020): FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial. In: British Journal of Cancer, Bd. 124, Nr. 3: S. 587-594

Westphalen, C. Benedikt; Heinemann, Volker; Tessen, Hans Werner; Groschek, Matthias; Hoeffkes, Heinz-Gert; Marschner, Norbert; Schulze, Mathias; Beringer, Andreas und Waldschmidt, Dirk (2020): Erlotinib plus Gemcitabin als Therapie bei Patienten mit metastasiertem Pankreaskarzinom: Ergebnisse einer nicht-interventionellen Studie. In: Zeitschrift für Gastroenterologie, Bd. 58, Nr. 4: S. 332-340

Millstein, Joshua; Battaglin, Francesca; Barrett, Malcolm; Cao, Shu; Zhang, Wu; Stintzing, Sebastian; Heinemann, Volker und Lenz, Heinz-Josef (2020): Partition: a surjective mapping approach for dimensionality reduction. In: Bioinformatics, Bd. 36, Nr. 3: S. 676-681

Mahajan, Ujjwal M.; Goni, Elisabetta; Langhoff, Enno; Li, Qi; Costello, Eithne; Greenhalf, William; Kruger, Stephan; Ormanns, Steffen; Halloran, Christopher; Ganeh, Paula; Marron, Manuela; Laemmerhirt, Felix; Zhao, Yue; Beyer, Georg; Weiss, Frank-Ulrich; Sendler, Matthias; Bruns, Christiane J.; Kohlmann, Thomas; Kirchner, Thomas; Werner, Jens; D'Haese, Jan G.; Bergwelt, Michael von; Heinemann, Volker; Neoptolemos, John P.; Buechler, Markus W.; Belka, Claus; Boeck, Stefan; Lerch, Markus M. und Mayerle, Julia (2020): Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer. In: Jnci Cancer Spectrum, Bd. 4, Nr. 1, pkz060

Schulz, Christoph; Heinemann, Volker; Heinrich, Kathrin; Haas, Michael; Holch, Julian W.; Fraccaroli, Alessia; Held, Swantje; Einem, Jobst C.von; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Kullmann, Frank; Moehler, Markus; Scheithauer, Werner; Jung, Andreas und Stintzing, Sebastian (2020): Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study. In: Anti-Cancer Drugs, Bd. 31, Nr. 8: S. 856-865

Stahler, Arndt; Stintzing, Sebastian; Modest, Dominik P.; Ricard, Ingrid; Giessen-Jung, Clemens; Kapaun, Christine; Ivanova, Boryana; Kaiser, Florian; Fischer von Weikersthal, Ludwig; Moosmann, Nicolas; Schalhorn, Andreas; Stauch, Martina; Kiani, Alexander; Held, Swantje; Decker, Thomas; Moehler, Markus; Neumann, Jens; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker (2020): Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials. In: Clinical Cancer Research, Bd. 26, Nr. 24: S. 6559-6567

Westphalen, C. Benedikt; Kukiolka, Tobias; Garlipp, Benjamin; Hahn, Lars; Fuchs, Martin; Malfertheiner, Peter; Reiser, Marcel; Kuetting, Fabian; Heinemann, Volker; Beringer, Andreas und Waldschmidt, Dirk T. (2020): Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional multi-center study. In: BMC Cancer, Bd. 20, Nr. 1

Cutsem, Eric van; Tempero, Margaret A.; Sigal, Darren; Oh, Do-Youn; Fazio, Nicola; Macarulla, Teresa; Hitre, Erika; Hammel, Pascal; Hendifar, Andrew E.; Bates, Susan E.; Li, Chung-Pin; Hingorani, Sunil R.; de la Fouchardiere, Christelle; Kasi, Anup; Heinemann, Volker; Maraveyas, Anthony; Bahary, Nathan; Layos, Laura; Sahai, Vaibhav; Zheng, Lei; Lacy, Jill; Park, Joon Oh; Portales, Fabienne; Oberstein, Paul; Wu, Wilson; Chondros, Dimitrios und Bullock, Andrea J. (2020): Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma. In: Journal of Clinical Oncology, Bd. 38, Nr. 27: S. 3185-3196

Nasseh, Daniel; Schneiderbauer, Sophie; Lange, Michael; Schweizer, Diana; Heinemann, Volker; Belka, Claus; Cadenovic, Ranko; Buysse, Laurence; Erickson, Nicole; Müller, Michael; Kortuem, Karsten; Niyazi, Maximilian; Marschner, Sebastian und Fey, Theres (2020): Optimizing the Analytical Value of Oncology-Related Data Based on an In-Memory Analysis Layer: Development and Assessment of the Munich Online Comprehensive Cancer Analysis Platform. In: Journal of Medical Internet Research, Bd. 22, Nr. 4, e16533

Mühlberg, Alexander; Katzmann, Alexander; Heinemann, Volker; Kärgel, Rainer; Wels, Michael; Taubmann, Oliver; Lades, Felix; Huber, Thomas; Maurus, Stefan; Holch, Julian; Faivre, Jean-Baptiste; Sühling, Michael; Nörenberg, Dominik und Remy-Jardin, Martine (2020): The Technome - A Predictive Internal Calibration Approach for Quantitative Imaging Biomarker Research. In: Scientific Reports, Bd. 10, Nr. 1, 1103 [PDF, 3MB]

Stintzing, Sebastian; Oostrum, Ilse van; Pescott, Chris P.; Ronga, Philippe; Heeg, Bart und Heinemann, Volker (2020): Cost-effectiveness of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in the first-line treatment of RAS wild-type metastatic colorectal cancer in Germany: data from the FIRE-3 (AIO KRK-0306) study. In: Journal of Medical Economics, Bd. 23, Nr. 5: S. 448-455

Attenberger, Ulrike; Rödel, Claus; Ghadimi, Michael; Piso, Pompilio; Arnold, Dirk; Folprecht, Gunnar; Geissler, Michael; Hegewisch-Becker, Susanna; Heinemann, Volker; Kasper, Stefan; Modest, Dominik; Reinacher-Schick, Anke; Seufferlein, Thomas; Stein, Alexander; Stintzin, Sebastian und Hofhein, Ralf-Dieter (2020): Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom – Interdisziplinäre Empfehlungen. In: Zeitschrift für Gastroenterologie, Bd. 58, Nr. 6: S. 577-582

Baumgarten, Louisa von; Kumbrink, Jörg; Jung, Andreas; Reischer, Anna; Flach, Madeleine; Liebmann, Sibylle; Metzeler, Klaus H.; Holch, Julian W.; Niyazi, Maximilian; Thon, Niklas; Straube, Andreas; Bergwelt-Baildon, Michael von; Heinemann, Volker; Kirchner, Thomas und Westphalen, Christoph Benedikt (2020): Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy. In: Theranostics, Bd. 10, Nr. 2: S. 856-866

Modest, Dominik Paul; Heinemann, Volker; Folprecht, Gunnar; Denecke, Timm; Pratschke, Johann; Lang, Hauke; Bemelmans, Marc; Becker, Thomas; Rentsch, Markus; Seehofer, Daniel; Bruns, Christiane J.; Gebauer, Bernhard; Held, Swantje; Stahler, Arndt; Heinrich, Kathrin; Einem, Jobst C. von; Stintzing, Sebastian; Neumann, Ulf P. und Ricard, Ingrid (2020): Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3-AIOKRK0306. In: Annals of Surgical Oncology, Bd. 27, Nr. 7: S. 2389-2401

Westphalen, Benedikt C.; Bokemeyer, Carsten; Buettner, Reinhard; Froehling, Stefan; Gaidzik, Verena I.; Glimm, Hanno; Hacker, Ulrich T.; Heinemann, Volker; Illert, Anna L.; Keilholz, Ulrich; Kindler, Thomas; Kirschner, Martin; Schilling, Bastian; Siveke, Jens T.; Schroeder, Thomas; Tischler, Verena; Wagner, Sebastian; Weichert, Wilko; Zips, Daniel und Loges, Sonja (2020): Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'. In: European Journal of Cancer, Bd. 135: S. 1-7

Kruger, Stephan; Schirle, Karoline; Haas, Michael; Crispin, Alexander; Schirra, Jörg; Mayerle, Julia; D'Haese, Jan G.; Kunz, Wolfgang G.; Ricke, Jens; Ormanns, Steffen; Kirchner, Thomas; Kobold, Sebastian; Ilmer, Matthias; Gebauer, Leonie; Westphalen, Christoph B.; Bergwelt-Baildon, Michael von; Werner, Jens; Heinemann, Volker und Boeck, Stefan (2020): Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox. In: Journal of Cancer Research and Clinical Oncology, Bd. 146, Nr. 2: S. 391-399

Bösch, Florian; Brüwer, Katharina; Altendorf-Hofmann, Annelore; Auernhammer, Christoph J.; Spitzweg, Christine; Westphalen, Benedikt; Boeck, Stefan; Schubert-Fritschle, Gabriele; Werner, Jens; Heinemann, Volker; Kirchner, Thomas; Angele, Martin K. und Knösel, Thomas (2019): Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia. In: Endocrine-Related Cancer, Bd. 26, Nr. 3: S. 293-301

Krüger, Stephan; Ilmer, Matthias; Kobold, Sebastian; Cadilha, Bruno L.; Endres, Stefan; Ormanns, Steffen; Schuebbe, Gesa; Renz, Bernhard W.; D'Haese, Jan G.; Schloesser, Hans; Heinemann, Volker; Subklewe, Marion; Böck, Stefan; Werner, Jens und Bergwelt-Baildon, Michael von (2019): Advances in cancer immunotherapy 2019-latest trends. In: Journal of Experimental & Clinical Cancer Research, Bd. 38, 268

Modest, Dominik P.; Martens, Uwe M.; Riera-Knorrenschild, Jörge; Greeve, Jobst; Florschuetz, Axel; Wessendorf, Swen; Ettrich, Thomas; Kanzler, Stephan; Noerenberg, Dominik; Ricke, Jens; Seidensticker, Max; Held, Swantje; Buechner-Steudel, Petra; Atzpodien, Jens; Heinemann, Volker; Seufferlein, Thomas; Tannapfel, Andrea; Reinacher-Schick, Anke C. und Geissler, Michael (2019): FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109). In: Journal of Clinical Oncology, Bd. 37, Nr. 35

Rohrmoser, Amy; Pichler, Theresia; Letsch, Anne; Westphalen, C. Benedikt; Keilholz, Ulrich; Heinemann, Volker; Goerling, Ute und Herschbach, Peter (2019): Cancer patients' expectations when undergoing extensive molecular diagnostics-A qualitative study. In: Psycho-Oncology, Bd. 29, Nr. 2: S. 423-429

Boesch, Florian; Todorova, Rumyana; Link, Helena; Westphalen, C. Benedikt; Böck, Stefan; Heinemann, Volker; Werner, Jens; Kirchner, Thomas; Angele, Martin K. und Neumann, Jens (2019): Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases. In: Journal of Cancer Research and Clinical Oncology, Bd. 145, Nr. 11: S. 2689-2697

Einem, Jobst Christian von; Guenther, Christine; Volk, Hans-Dieter; Gruetz, Gerald; Hirsch, Daniela; Salat, Christoph; Stoetzer, Oliver; Nelson, Peter J.; Michl, Marlies; Modest, Dominik P.; Holch, Julian W.; Angele, Martin; Bruns, Christiane; Niess, Hanno und Heinemann, Volker (2019): Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial. In: International Journal of Cancer, Bd. 145, Nr. 6: S. 1538-1546

Burzykowski, Tomasz; Coart, Elisabeth; Saad, Everardo D.; Shi, Qian; Sommeijer, Dirkje W.; Bokemeyer, Carsten; Diaz-Rubio, Eduardo; Douillard, Jean-Yves; Falcone, Alfredo; Fuchs, Charles S.; Goldberg, Richard M.; Hecht, J. Randolph; Hoff, Paulo M.; Hurwitz, Herbert; Kabbinavar, Fairooz F.; Koopman, Miriam; Maughan, Timothy S.; Punt, Cornelis J. A.; Saltz, Leonard; Schmoll, Hans-Joachim; Seymour, Matthew T.; Tebbutt, Niall C.; Tournigand, Christophe; Van Cutsem, Eric; de Gramont, Aimery; Zalcberg, John R.; Buyse, Marc; Adam, Rene; Adams, Richard; Ajani, Jaffer; Allegra, Carmen Joseph; Andre, Thierry; Arnold, Dirk; Bachet, Jean-Baptiste; Benson, Al Bowen; Berlin, Jordan; Bleiberg, Harry; Bodoky, Gyorgy; Buyse, Marc; Chibaudel, Benoist; Diaz-Rubio, Eduardo; Douillard, Jean-Yves; Ellis, Lee; Eng, Cathy; Falcone, Alfredo; Franko, Jan; Fuchs, Charles S.; Fujii, Masashi; Giantonio, Bruce J.; Goldberg, Richard M.; de Gramont, Aimery; Grothey, Axel; Haller, Daniel; Hamilton, Stan R.; Hausner, Petr F.; Hecht, J. Randolph; Heinemann, Volker; Herrera, Alain; Hochster, Howard S.; Hoff, Paulo M.; Jonker, Derek J.; Kaplan, Rick; Koeberle, Dieter; Kopetz, Scott; Labianca, Roberto F.; Larsen, Annette K.; Lenz, Heinz-Joseph; Lieu, Christopher; Louvet, Christophe; Loupakis, Fotios; Marshall, John; Maughan, Timothy S.; Mayer, Robert J.; Meropol, Neal J.; Mitchell, Edith P.; O'Connell, Michael J.; Peeters, Marc; Porschen, Rainer; Price, Timothy; Punt, Cornelis J. A.; Salem, Mohamed E.; Saltz, Leonard; Schilsky, Richard; Schmoll, Hans-Joachim; Seymour, Matthew T.; Shmueli, Einat Shacham; Shi, Qian; Sobrero, Alberto; Souglakos, John; Tabernero, Josep; Taieb, Julien; Tebbutt, Niall C.; Tejpar, Sabine; Tempero, Margaret; Tournigand, Christophe; Tsuji, Yasushi; Van Cutsem, Eric; Venook, Alan P.; Yoshino, Takayuki; Weinberg, Benjamin A.; Wolmark, Norman und Zalcberg, John R. (2019): Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer. In: Jama Network Open, Bd. 2, Nr. 9, e1911750

Riechelmann, Rachel P.; Srimuninnimit, Vichien; Bordonaro, Roberto; Kavan, Petr; Di Bartolomeo, Maria; Maiello, Evaristo; Cicin, Irfan; Garcia-Alfonso, Pilar; Chau, Ian; Fedyanin, Mikhail Y.; Fernandez Martos, Carlos; Ter-Ovanesov, Mikhail; Peeters, Marc; Ko, Yoo-Joung; Yalcin, Suayib; Karthaus, Meinolf; Aparicio, Jörge; Heinemann, Volker; Picard, Pascaline; Bury, Denise; Drea, Edward und Sobrero, Alberto (2019): Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP). In: Clinical Colorectal Cancer, Bd. 18, Nr. 3

Westphalen, C. Benedikt; Heinrich, Kathrin; Böck, Stefan und Heinemann, Volker (2019): Molekulare Charakterisierung des Pankreaskarzinoms. Therapeutische Implikationen. In: Onkologe, Bd. 25, Nr. 8: S. 704-709

Puccini, Alberto; Loupakis, Fotios; Stintzing, Sebastian; Cao, Shu; Battaglin, Francesca; Togunaka, Ryuma; Naseem, Madiha; Berger, Martin D.; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Salhia, Bodour; Mumenthaler, Shannon M.; Weisenberger, Daniel J.; Liang, Gangning; Cremolini, Chiara; Heinemann, Volker; Falcone, Alfredo; Millstein, Joshua und Lenz, Heinz-Josef (2019): Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3. In: European Journal of Cancer, Bd. 111: S. 138-147

Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia; Götze, Thorsten O.; Meiler, Johannes; Kasper, Stefan; Kopp, Hans-Georg; Mayer, Frank; Haag, Georg Martin; Luley, Kim; Lindig, Udo; Schmiegel, Wolff; Pohl, Michael; Stoehlmacher, Jan; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Fischbach, Wolfgang; Mahlberg, Rolf; Trojan, Jörg; Königsmann, Michael; Martens, Uwe M.; Thuss-Patience, Peter; Egger, Matthias; Block, Andreas; Heinemann, Volker; Illerhaus, Gerald; Moehler, Markus; Schenk, Michael; Kullmann, Frank; Behringer, Dirk M.; Heike, Michael; Pink, Daniel; Teschendorf, Christian; Loehr, Carmen; Bernhard, Helga; Schuch, Gunter; Rethwisch, Volker; Fischer von Weikersthal, Ludwig; Hartmann, Jörg T.; Kneba, Michael; Daum, Severin; Schulmann, Karsten; Weniger, Jörg; Belle, Sebastian; Gaiser, Timo; Oduncu, Fuat S.; Guentner, Martina; Hozaeel, Wael; Reichart, Alexander; Jaeger, Elke; Kraus, Thomas; Moenig, Stefan; Bechstein, Wolf O.; Schuler, Martin; Schmalenberg, Harald und Hofheinz, Ralf D. (2019): Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. In: Lancet, Bd. 393, Nr. 10184: S. 1948-1957

Tokunaga, Ryuma; Cao, Shu; Naseem, Madiha; Lo, Jae Ho; Battaglin, Francesca; Puccini, Alberto; Berger, Martin D.; Soni, Shivani; Millstein, Joshua; Zhang, Wu; Stintzing, Sebastian; Loupakis, Fotios; Cremolini, Chiara; Heinemann, Volker; Falcone, Alfredo und Lenz, Heinz-Josef (2019): Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy. In: Clinical Colorectal Cancer, Bd. 18, Nr. 1, E8-E19

Bormann, Felix; Stinzing, Sebastian; Tierling, Sascha; Morkel, Markus; Markelova, Maria Rivera; Walter, Jorn; Weichert, Wilko; Rossner, Florian; Kuhn, Natalia; Perner, Juliane; Dietz, Johanna; Ispasanie, Sylvia; Dietel, Manfred; Schäfer, Reinhold; Heinemann, Volker und Sers, Christine (2019): Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer. In: International Journal of Cancer, Bd. 144, Nr. 3: S. 569-581

Modest, Dominik Paul; Fischer von Weikersthal, Ludwig; Decker, Thomas; Vehling-Kaiser, Ursula; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Reddemann, Christina Peveling Genannt; Graeven, Ullrich; Schuch, Gunter; Schwaner, Ingo; Stahler, Arndt; Jung, Andreas; Kirchner, Thomas; Held, Swantje; Stintzing, Sebastian; Giessen-Jung, Clemens und Heinemann, Volker (2019): Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled StudyXELAVIRI (AIO KRK0110). In: Journal of Clinical Oncology, Bd. 37, Nr. 1

Laurent-Puig, Pierre; Grisoni, Marie-Lise; Heinemann, Volker; Liebaert, Francois; Neureiter, Daniel; Jung, Andreas; Montestruc, Francois; Gaston-Mathe, Yann; Thiebaut, Raphaeele und Stintzing, Sebastian (2019): Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer. In: Clinical Cancer Research, Bd. 25, Nr. 1: S. 134-141

Suenaga, Mitsukuni; Stintzing, Sebastian; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Okazaki, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Schirripa, Marta; Soni, Shivani; Barzi, Afsaneh; Heinemann, Volker und Lenz, Heinz-Josef (2019): Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial. In: European Journal of Cancer, Bd. 107: S. 100-114

Pichler, Theresia; Dinkel, Andreas; Marten-Mittag, Birgitt; Hermelink, Kerstin; Telzerow, Eva; Ackermann, Ulrike; Belka, Claus; Combs, Stephanie E.; Gratzke, Christian; Gschwend, Jürgen; Harbeck, Nadia; Heinemann, Volker; Herkommer, Kathleen; Kiechle, Marion; Mahner, Sven; Pigorsch, Steffi; Rauch, Josefine; Stief, Christian; Beckmann, Jürgen; Heussner, Pia und Herschbach, Peter (2019): Factors associated with the decline of psychological support in hospitalized patients with cancer. In: Psycho-Oncology, Bd. 28, Nr. 10: S. 2049-2059

Holch, Julian W.; Ricard, Ingrid; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Scholz, Michael; Müller, Sebastian; Link, Hartmut; Rost, Andreas; Höffkes, Heinz-Gert; Moehler, Markus; Lindig, Reinhard Udo; Miller-Phillips, Lisa; Kirchner, Thomas; Jung, Andreas; Einem, Jobst C. von; Modest, Dominik Paul und Heinemann, Volker (2018): Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial. In: International Journal of Cancer, Bd. 142, Nr. 5: S. 1047-1055

Modest, Dominik P.; Denecke, Timm; Pratschke, J.; Ricard, Ingrid; Lang, H.; Bemelmans, M.; Becker, T.; Rentsch, Markus; Seehofer, Daniel; Bruns, Christiane J.; Gebauer, B.; Modest, H. I.; Held, S.; Folprecht, Gunnar; Heinemann, Volker und Neumann, Ulf Peter (2018): Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3. In: European Journal of Cancer (EJC), Bd. 88: S. 77-86

Bokemeyer, Carsten; Busse, Reinhard; Engel, Jutta; Gebauer, Alexander; Hallek, Michael; Heinemann, Volker; Lüftner, Diana und Wörmann, Bernhard (2018): Der ältere Krebspatient - Herausforderungen im Krankenhaus und in der Praxis. In: Oncology Research and Treatment, Bd. 41, Nr. Suppl 3: S. 2-26 [PDF, 569kB]

Froelich, Matthias F.; Stintzing, Sebastian; Kumbrink, Jörg; Grünewald, Thomas G. P.; Mansmann, Ulrich; Heinemann, Volker; Kirchner, Thomas und Jung, Andreas (2018): The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximab. In: OncoTarget, Bd. 9, Nr. 54: S. 30279-30288 [PDF, 3MB]

Neumann, Jens; Heinemann, Volker; Engel, Jutta; Kirchner, Thomas und Stintzing, Sebastian (2018): The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer. In: Virchows Archiv : an international journal of pathology, Bd. 473, Nr. 2: S. 199-207

Baraniskin, Alexander; Buchberger, Barbara; Pox, Christian; Graeven, Ulli; Holch, Julian W.; Schmiegel, Wolff und Heinemann, Volker (2018): Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis. In: European Journal of Cancer, Bd. 106: S. 37-44

Hofmann, Felix O.; Holch, Julian W.; Heinemann, Volker; Ricard, Ingrid; Reiser, Maximilian F.; Baumann, Alena B.; Hesse, Nina; D'Anastasi, Melvin; Modest, Dominik P.; Stintzing, Sebastian und Sommer, Wieland H. (2018): Prognostic value of radiologically enlarged lymph nodes in patients with metastatic colorectal cancer: Subgroup findings of the randomized, open-label FIRE-3/AIO KRK0306 trial. In: European Journal of Radiology, Bd. 100: S. 124-129

Salem, Mohamed E.; Yin, Jun; Weinberg, Benjamin A.; Renfro, Lindsay A.; Pederson, Levi D.; Maughan, Timothy S.; Adams, Richard A.; Cutsem, Eric van; Falcone, Alfredo; Tebbutt, Niall C.; Seymour, Matthew T.; Diaz-Rubio, Eduardo; Aranda, Enrique; Bokemeyer, Carsten; Heinemann, Volker; Wasan, Harpreet; Gramont, Aimery de; Grothey, Axel; Shi, Qian; Sargent, Daniel J. und Marshall, John L. (2018): Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database. In: European Journal of Cancer, Bd. 103: S. 205-213

Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Cremolini, Chiara; Lonardi, Sara; Bergamo, Francesca; Ning, Yang; Yamamoto, Noriko; Okazaki, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Gopez, Roel; Barzi, Afsaneh; Yamaguchi, Toshiharu; Stintzing, Sebastian; Heinemann, Volker; Loupakis, Fotios; Falcone, Alfredo und Lenz, Heinz-Josef (2018): Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer. In: Pharmacogenomics Journal, Bd. 18, Nr. 5: S. 623-632

Schulz, Christoph; Zhang, Wu; Lenz, Heinz-Josef; Neumann, Jens; Kullmann, Frank; Kunzmann, Volker; Fuchs, Martin; Heinemann, Volker; Holch, Julian Walter und Stintzing, Sebastian (2018): Germline polymorphisms (SNPs) to predict toxicity and efficacy in FLOT-treated patients with locally advanced gastroesophageal junction or gastric adenocarcinoma-data from the NeoFLOT study. In: Translational Cancer Research, Bd. 7, Nr. 6: S. 1393-1405

Günther, Michael; Veninga, Vivien; Kumbrink, Jörg; Haas, Michael; Westphalen, C. Benedikt; Kruger, Stephan; Heinemann, Volker; Kirchner, Thomas; Böck, Stefan; Jung, Andreas und Ormanns, Steffen (2018): POLE gene hotspot mutations in advanced pancreatic cancer. In: Journal of Cancer Research and Clinical Oncology, Bd. 144, Nr. 11: S. 2161-2166

Winter, Katharina S.; Hofmann, Felix O.; Thierfelder, Kolja M.; Holch, Julian W.; Hesse, Nina; Baumann, Alena B.; Modest, Dominik P.; Stintzing, Sebastian; Heinemann, Volker; Ricke, Jens; Sommer, Wieland H. und D'Anastasi, Melvin (2018): Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases. In: European Radiology, Bd. 28, Nr. 11: S. 4839-4848

Holch, Julian Walter; Michl, Marlies; Heinemann, Volker und Erickson, Nicole (2018): Vitamine und Spurenelemente in der Onkologie. In: Aktuelle Ernährungsmedizin, Bd. 43, Nr. 3: S. 156-161

Berger, Martin D.; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Yang, Dongyun; Sunakawa, Yu; Matsusaka, Satoshi; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Hanna, Diana L.; Soni, Shivani; Puccini, Alberto; Zhang, Wu; Cremolini, Chiara; Falcone, Alfredo; Loupakis, Fotios und Lenz, Heinz-Josef (2018): A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab. In: Clinical Cancer Research, Bd. 24, Nr. 4: S. 784-793

Froelich, Matthias F.; Heinemann, Volker; Sommer, Wieland H.; Holch, Julian W.; Schöppe, Franziska; Hesse, Nina; Baumann, Alena B.; Kunz, Wolfgang G.; Reiser, Maximilian F.; Ricke, Jens; D'Anastasi, Melvin; Stintzing, Sebastian; Modest, Dominik P.; Kazmierczak, Philipp M. und Hofmann, Felix O. (2018): CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial. In: European Radiology, Bd. 28, Nr. 12: S. 5284-5292

McSkane, Michelle; Stintzing, Sebastian; Heinemann, Volker; Puccini, Alberto; Naseem, Madiha; Cao, Shu; Lenz, Heinz-Josef und Jelas, Ivan (2018): Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study. In: Clinical Colorectal Cancer, Bd. 17, Nr. 3: S. 215-222

Gibbs, Peter; Heinemann, Volker; Sharma, Navesh K.; Taieb, Julien; Ricke, Jens; Peeters, Marc; Findlay, Michael; Robinson, Bridget; Jackson, Christopher; Strickland, Andrew; Gebski, Val; Buskirk, Mark van; Zhao, Huaqing und Hazel, Guy van (2018): Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies. In: Clinical Colorectal Cancer, Bd. 17, Nr. 4, E617-E629

Sjoquist, Katrin M.; Renfro, Lindsay A.; Simes, R. John; Tebbutt, Niall C.; Clarke, Stephen; Seymour, Matthew T.; Adams, Richard; Maughan, Timothy S.; Saltz, Leonard; Goldberg, Richard M.; Schmoll, Hans-Joachim; Cutsem, Eric van; Douillard, Jean-Yves; Hoff, Paulo M.; Hecht, Joel Randolph; Tournigand, Christophe; Punt, Cornelis J. A.; Koopman, Miriam; Hurwitz, Herbert; Heinemann, Volker und Zalcberg, John R. (2018): Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project. In: Jnci-Journal of the National Cancer Institute, Bd. 110, Nr. 6, djx253: S. 638-648

Schirripa, Marta; Zhang, Wu; Yang, Dongyun; Cao, Shu; Okazaki, Satoshi; Loupakis, Fotios; Berger, Martin D.; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Alberti, Giulia; West, Jordan D.; Lonardi, Sara; Khoukaz, Taline; Bergamo, Francesca; Battaglin, Francesca; Antoniotti, Carlotta; Falcone, Alfredo; Stintzing, Sebastian; Heinemann, Volker und Lenz, Heinz-Josef (2018): NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.
In: PLOS One 13(3), e0193640 [PDF, 2MB]

Holch, Julian W.; Ricard, Ingrid; Stintzing, Sebastian; Modest, Dominik P. und Heinemann, Volker (Januar 2017): The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials. In: European Journal of Cancer, Bd. 70: S. 87-98

Herbst, Andreas; Vdovin, Nikolay; Gacesa, Sanja; Philipp, Alexander; Nagel, Dorothea; Holdt, Lesca M.; Winkel, Mark op den; Heinemann, Volker; Stieber, Petra; Graeven, Ullrich; Reinacher-Schick, Anke; Arnold, Dirk; Ricard, Ingrid; Mansmann, Ulrich; Hegewisch-Becker, Susanna und Kolligs, Frank T. (2017): Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer. In: International Journal of Cancer, Bd. 140, Nr. 9: S. 2134-2144

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; Crispin, Alexander; Schalhorn, Andreas; Stintzing, Sebastian; Giessen-Jung, Clemens; Fischer von Weikersthal, Ludwig; Vehling-Kaiser, Ursula; Stauch, Martina; Quietzsch, Detlef; Holch, Julian W.; Kruger, Stephan; Haas, Michael; Michl, Marlies; Einem, Jobst von; Kirchner, Thomas; Jung, Andreas und Modest, Dominik P. (2017): Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer. In: Anti-cancer drugs, Bd. 28, Nr. 7: S. 717-722 [PDF, 422kB]

Modest, Dominik P.; Ricard, Ingrid; Stintzing, Sebastian; Fischer von Weikersthal, L.; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Al-Batran, S.-E.; Heintges, T.; Kahl, C.; Seipelt, G.; Kullmann, F.; Scheithauer, W.; Moehler, M.; Westphalen, C. B.; Holch, Julian W.; Einem, J. C. von; Held, S. und Heinemann, Volker (2017): Evaluation of survival across several treatment lines in metastatic colorectal cancer: analysis of the FIRE-3 trial (AIO KRK0306). In: European Journal of Cancer, Bd. 84: S. 262-269

Modest, Dominik P.; Denecke, Timm; Pratschke, J.; Ricard, Ingrid; Lang, H.; Bemelmans, M.; Becker, T.; Rentsch, M.; Seehofer, D.; Bruns, C. J.; Gebauer, B.; Modest, H. I.; Held, S.; Folprecht, Gunnar; Heinemann, Volker und Neumann, Ulf Peter (2017): Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3. In: European Journal of Cancer, Bd. 88: S. 77-86

Paprottka, Karolin J.; Todica, Andrei; Ilhan, Harun; Rübenthaler, Johannes; Schoeppe, Franziska; Michl, Marlies; Heinemann, Volker; Bartenstein, Peter; Reiser, Maximilian F. und Paprottka, Philipp M. (2017): Evaluation of Visualization Using a 50/50 (Contrast Media/Glucose 5% Solution) Technique for Radioembolization as an Alternative to a Standard Sandwich Technique. In: Cardiovascular and interventional Radiology, Bd. 40, Nr. 11: S. 1740-1747

Kruger, Stephan; Haas, Michael; Burkl, Carolin; Goehring, Peter; Kleespies, Axel; Röder, Falk; Gallmeier, Eike; Ormanns, Steffen; Westphalen, Christoph Benedikt; Heinemann, Volker; Rank, Andreas und Boeck, Stefan (2017): Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study. In: Thrombosis Research, Bd. 157: S. 9-15

Holch, Julian Walter; Metzeler, Klaus Hans; Jung, Andreas; Riedmann, Kristina; Jost, Philipp Jakob; Weichert, Wilko; Kirchner, Thomas; Heinemann, Volker und Westphalen, Christoph Benedikt (2017): Universal Genomic Testing: The next step in oncological decision-making or a dead end street? In: European Journal of Cancer, Bd. 82: S. 72-79

Bächmann, Sibylle; Ormanns, Steffen; Haas, Michael; Krüger, Stephan; Remold, Anna; Modest, Dominik Paul; Kirchner, Thomas; Jung, Andreas; Werner, Jens; Heinemann, Volker und Böck, Stefan (2017): Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research. In: BMC Cancer 17:374 [PDF, 614kB]

Haas, Michael; Ormanns, Steffen; Bächmann, Sibylle; Remold, Anna; Krüger, Stephan; Westphalen, Christoph B.; Siveke, Jens T.; Wenzel, Patrick; Schlitter, Anna Melissa; Esposito, Irene; Quietzsch, Detlef; Clemens, Michael R.; Kettner, Erika; Laubender, Rüdiger P.; Jung, Andreas; Kirchner, Thomas; Böck, Stefan und Heinemann, Volker (2017): Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer. In: British Journal of Cancer, Bd. 116, Nr. 11: S. 1462-1469

Ormanns, Steffen; Haas, Michael; Remold, Anna; Kruger, Stephan; Holdenrieder, Stefan; Kirchner, Thomas; Heinemann, Volker und Boeck, Stefan (2017): The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy. In: International Journal of Molecular Sciences, Bd. 18, Nr. 5, 1094 [PDF, 1MB]

Holch, Julian Walter und Heinemann, Volker (2017): Response to letter entitled: Distinct metastatic patterns in colorectal cancer patients. In: European Journal of Cancer, Bd. 77: S. 1-2

Berger, Martin D.; Yamauchi, Shinichi; Cao, Shu; Hanna, Diana L.; Sunakawa, Yu; Schirripa, Marta; Matsusaka, Satoshi; Yang, Dongyun; Groshen, Susan; Zhang, Wu; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Lonardi, Sara; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; Loupakis, Fotios; Stintzing, Sebastian und Lenz, Heinz-Josef (2017): Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials. In: European Journal of Cancer, Bd. 77: S. 13-20

Kruger, Stephan; Legenstein, Marie-Louise; Rösgen, Verena; Haas, Michael; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Ormanns, Steffen; Kirchner, Thomas; Heinemann, Volker; Holdenrieder, Stefan und Boeck, Stefan (2017): Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer. In: Oncoimmunology, Bd. 6, Nr. 5, e1310358

Holch, Julian Walter; Westphalen, Benedikt; Hiddemann, Wolfgang; Heinemann, Volker; Jung, Andreas und Metzeler, Klaus (2017): Präzisionsonkologie und molekulare Tumorboards – Konzepte, Chancen und Herausforderungen. In: Deutsche Medizinische Wochenschrift, Bd. 142, Nr. 22: S. 1676-1684

Holch, Julian Walter; Michl, Marlies; Heinemann, Volker und Erickson, Nicole (2017): Vitamine und Spurenelemente in der Onkologie. In: Deutsche Medizinische Wochenschrift, Bd. 142, Nr. 12: S. 896-902

Einem, Jobst C. von; Peter, Sylvia; Günther, Christine; Volk, Hans-Dieter; Gürtz, Gerald; Salat, Christoph; Stötzer, Oliver; Nelson, Peter J.; Michl, Marlies; Modest, Dominik P.; Holch, Julian W.; Angele, Martin; Bruns, Christiane; Niess, Hanno und Heinemann, Volker (2017): Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1-a phase I, first in human, first in class trial. In: Oncotarget, Bd. 8, Nr. 46: S. 80156-80166

Böck, Stefan und Heinemann, Volker (2017): Improving post-surgical management of resected pancreatic cancer. In: Lancet, Bd. 390, Nr. 10097: S. 847-848

Modest, Dominik P.; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Scheithauer, Werner; Kirchner, Thomas; Jung, Andreas; Stauch, Martina; Einem, Jobst Christian von; Möhler, Markus; Held, Swantje und Heinemann, Volker (2017): Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306). In: International Journal of Cancer, Bd. 140, Nr. 8: S. 1918-1925

Renz, Bernhard W.; Böck, Stefan; Röder, Falk; Trumm, Christoph; Heinemann, Volker und Werner, Jens (2017): Oligometastatic Disease in Pancreatic Cancer - How to Proceed? In: Visceral Medicine, Bd. 33, Nr. 1: S. 36-41

Holch, Julian Walter; Demmer, Maximilian; Lamersdorf, Charlotte; Michl, Marlies; Schulz, Christoph; Einem, Jobst Christian von; Modest, Dominik Paul und Heinemann, Volker (2017): Pattern and Dynamics of Distant Metastases in Metastatic Colorectal Cancer. In: Visceral Medicine, Bd. 33, Nr. 1: S. 70-75

Cohn, Allen Lee; Yoshino, Takayuki; Heinemann, Volker; Obermannova, Radka; Bodoky, Gyorgy; Prausova, Jana; Garcia-Carbonero, Rocio; Ciuleanu, Tudor; Garcia-Alfonso, Pilar; Portnoy, David C.; Cutsem, Eric van; Yamazaki, Kentaro; Clingan, Philip R.; Polikoff, Jonathon; Lonardi, Sara; O'Brien, Lisa M.; Gao, Ling; Yang, Ling; Ferry, David; Nasroulah, Federico und Tabernero, Josep (2017): Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial. In: Cancer Chemotherapy and Pharmacology, Bd. 80, Nr. 3: S. 599-608 [PDF, 1MB]

Strobl, Frederik Franz; Schwarz, Jens Benjamin; Häussler, Sophia Marie; Paprottka, Philipp Marius; Rist, Carsten; Thierfelder, Kolja Martin; Böck, Stefan; Heinemann, Volker; Reiser, Maximilian Ferdinand und Trumm, Christoph Gregor (2017): Percutaneous CT fluoroscopy-guided core biopsy of pancreatic lesions: technical and clinical outcome of 104 procedures during a 10-year period. In: Acta Radiologica, Bd. 58, Nr. 8: S. 906-913 [PDF, 341kB]

Okazaki, Satoshi; Stintzing, Sebastian; Sunakawa, Yu; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Matsusaka, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; West, Jordan D.; Gopez, Roel; Akihito, Tsuji; Ichikawa, Wataru; Heinemann, Volker; DePaolo, R. William und Lenz, Heinz-Josef (2017): Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer. In: International Journal of Cancer, Bd. 141, Nr. 6: S. 1222-1230

Schmiegel, Wolff; Buchberger, Barbara; Follmann, Markus; Graeven, Ullrich; Heinemann, Volker; Langer, Thomas; Nothacker, Monika; Porschen, Rainer; Rödel, Claus; Rösch, Thomas; Schmitt, Wolfgang; Wesselmann, Simone und Pox, Christian (2017): S3-Leitlinie – Kolorektales Karzinom. In: Zeitschrift für Gastroenterologie, Bd. 55, Nr. 12: S. 1344-1498

Wasan, Harpreet S.; Gibbs, Peter; Sharma, Navesh K.; Taieb, Julien; Heinemann, Volker; Ricke, Jens; Peeters, Marc; Findlay, Michael; Weaver, Andrew; Mills, Jamie; Wilson, Charles; Adams, Richard; Francis, Anne; Moschandreas, Joanna; Virdee, Pradeep S.; Dutton, Peter; Love, Sharon; Gebski, Val; Gray, Alastair; Hazel, Guy van und Sharma, Ricky A. (2017): First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. In: Lancet Oncology, Bd. 18, Nr. 9: S. 1159-1171

Schirripa, Marta; Zhang, Wu; Heinemann, Volker; Cao, Shu; Okazaki, Satoshi; Yang, Dongyun; Loupakis, Fotios; Berger, Martin D.; Ning, Yan; Miyamoto, Yuji; Suenaga, Mitsukuni; Gopez, Roel F.; West, Jordan D.; Hanna, Diana; Barzi, Afsaneh; Falcone, Alfredo; Stintzing, Sebastian und Lenz, Heinz-Josef (2017): Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial. In: International Journal of Cancer, Bd. 141, Nr. 2: S. 383-392

Schiergens, Tobias S.; Renz, Bernhard W.; Reu, Simone; Neumann, Jens; Al-Sayegh, Rami; Niess, Hanno; Ilmer, Matthias; Kruger, Stephan; Böck, Stefan; Heinemann, Volker; Werner, Jens und Kleespies, Axel (2017): Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer. In: Journal of Gastrointestinal Surgery, Bd. 21, Nr. 11: S. 1775-1783

Mahlberg, Rolf; Lorenzen, Sylvie; Thuss-Patience, Peter; Heinemann, Volker; Pfeiffer, Per und Mohler, Markus (2017): New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin. In: Chemotherapy, Bd. 62, Nr. 1: S. 62-70

Hichert, Vivien; Scholl, Catharina; Steffens, Michael; Paul, Tanusree; Schumann, Christian; Rüdiger, Stefan; Böck, Stefan; Heinemann, Volker; Kächele, Volker; Seufferlein, Thomas und Stingl, Julia (2017): Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash. In: Oncotarget, Bd. 8, Nr. 21: S. 35193-35204

Renfro, Lindsay A.; Goldberg, Richard M.; Grothey, Axel; Sobrero, Alberto; Adams, Richard; Seymour, Matthew T.; Heinemann, Volker; Schmoll, Hans-Joachim; Douillard, Jean-Yves; Hurwitz, Herbert; Fuchs, Charles S.; Diaz-Rubio, Eduardo; Porschen, Rainer; Tournigand, Christophe; Chibaudel, Benoist; Hoff, Paulo M.; Kabbinavar, Fairooz F.; Falcone, Alfredo; Tebbutt, Niall C.; Punt, Cornelis J. A.; Hecht, J. Randolph; Souglakos, John; Bokemeyer, Carsten; Cutsem, Eric van; Saltz, Leonard; Gramont, Aimery de und Sargent, Daniel J. (2017): Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancerologie Digestive Database. In: Journal of Clinical Oncology, Bd. 35, Nr. 17: S. 1929-1937

Moehler, Markus; Mahlberg, Rolf; Heinemann, Volker; Obermannová, Radka; Kubala, Eugen; Melichar, Bohuslav; Weinmann, Arndt; Scigalla, Paul; Tesařová, Marietta; Janda, Petr; Hédouin-Biville, Fabienne und Mansoor, Wasat (2017): Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naive advanced or metastatic esophagogastric cancer. In: Gastric Cancer, Bd. 20, Nr. 2: S. 358-367

Tejpar, Sabine; Stintzing, Sebastian; Ciardiello, Fortunato; Tabernero, Josep; Cutsem, Eric van; Beier, Frank; Esser, Regina; Lenz, Heinz-Josef und Heinemann, Volker (2017): Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer Retrospective Analyses of the CRYSTAL and FIRE-3 Trials. In: Jama Oncology, Bd. 3, Nr. 2: S. 194-201

Modest, Dominik P.; Ricard, Ingrid; Heinemann, Volker; Hegewisch-Becker, S.; Schmiegel, W.; Porschen, R.; Stintzing, Sebastian; Graeven, U.; Arnold, D.; Fischer von Weikersthal, L.; Giessen-Jung, Clemens; Stahler, A.; Schmoll, H. J.; Jung, A.; Kirchner, T.; Tannapfel, A. und Reinacher-Schick, A. (September 2016): Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. In: Annals of Oncology, Bd. 27, Nr. 9: S. 1746-1753 [PDF, 410kB]

Okazaki, Satoshi; Loupakis, Fotios; Stintzing, Sebastian; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Sunakawa, Yu; Stremitzer, Stefan; Matsusaka, Satoshi; Berger, Martin D.; Parekh, Anish; West, Jordan D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; DePaolo, R. William und Lenz, Heinz-Josef (2016): Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab. In: Molecular Cancer therapeutics, Bd. 15, Nr. 7: S. 1740-1745

Renfro, Lindsay A.; Loupakis, Fotios; Adams, Richard A.; Seymour, Matthew T.; Heinemann, Volker; Schmoll, Hans-Joachim; Douillard, Jean-Yves; Hurwitz, Herbert; Fuchs, Charles S.; Diaz-Rubio, Eduardo; Porschen, Rainer; Tournigand, Christophe; Chibaudel, Benoist; Falcone, Alfredo; Tebbutt, Niall C.; Punt, Cornelis J. A.; Hecht, J. Randolph; Bokemeyer, Carsten; Cutsem, Eric van; Goldberg, Richard M.; Saltz, Leonard B.; Gramont, Aimery de; Sargent, Daniel J. und Lenz, Heinz-Josef (2016): Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database. In: Journal of Clinical Oncology, Bd. 34, Nr. 2: S. 144-150

Hazel, Guy A. van; Heinemann, Volker; Sharma, Navesh K.; Findlay, Michael P. N.; Ricke, Jens; Peeters, Marc; Perez, David; Robinson, Bridget A.; Strickland, Andrew H.; Ferguson, Tom; Rodríguez, Javier; Kröning, Hendrik; Wolf, Ido; Ganju, Vinod; Walpole, Euan; Boucher, Eveline; Tichler, Thomas; Shacham-Shmueli, Einat; Powell, Alex; Eliadis, Paul; Isaacs, Richard; Price, David; Moeslein, Fred; Taieb, Julien; Bower, Geoff; Gebski, Val; Buskirk, Mark van; Cade, David N.; Thurston, Kenneth und Gibbs, Peter (2016): SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer. In: Journal of Clinical Oncology, Bd. 34, Nr. 15: S. 1723-1731

Modest, Dominik Paul; Held, Swantje und Heinemann, Volker (2016): Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial Reply. In: Journal of Clinical Oncology, Bd. 34, Nr. 13: S. 1565-1566

Cutsem, Eric van; Lenz, Heinz-Josef; Furuse, Junji; Tabernero, Josep; Heinemann, Volker; Ioka, Tatsuya; Bazin, Igor; Ueno, Makoto; Csõszi, Tibor; Wasan, Harpreet; Melichar, Bohuslav; Karasek, Petr; Macarulla, Teresa; Ponce, Carmen Guillen; Kalinka-Warzocha, Ewa; Horvath, Zsolt; Prenen, Hans; Schlichting, Michael; Mehdi, Fazal und Bendell, Johanna C. (2016): Evofosfamide (TH-302) in combination with gemcitabine in previously untreated patients with metastatic or locally advanced unresectable pancreatic ductal adenocarcinoma: Primary analysis of the randomized, double-blind phase III MAESTRO study. In: Journal of Clinical Oncology, Bd. 34, Nr. 4

Okazaki, Satoshi; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Matsusaka, Satoshi; Berger, Martin D.; West, Jordan D.; Miyamoto, Yuji; Suenaga, Mitsukuni und Lenz, Heinz-Josef (2016): Association of TLR9 polymorphism with overall survival in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab enrolled in FIRE3. In: Journal of Clinical Oncology, Bd. 34, Nr. 4

Stintzing, Sebastian; Modest, Dominik Paul; Jung, Andreas; Kirchner, Thomas; Schäfer, Reinhold; Sers, Christine; Hildebrandt, Bert; Daum, Severin; Folprecht, Gunnar; Schuler, Martin H.; Kasper, Stefan; Trojan, Jorg; Jaeger, Dirk; Schulze-Bergkamen, Henning; Fischer von Weikersthal, Ludwig; Schalhorn, Alexander und Heinemann, Volker (2016): Differences in gene-expression in mCRC tissue samples with regard to tumor location and used chemotherapeutic substances: Data of the FIRE-1 study. In: Journal of Clinical Oncology, Bd. 34, Nr. 4

Berger, Martin D.; Stintzing, Sebastian; Heinemann, Volker; Yang, Dongyun; Sunakawa, Yu; Ning, Yan; Matsusaka, Satoshi; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; West, Jordan David; Zhang, Wu; Petasis, Nicos und Lenz, Heinz-Josef (2016): Serum amyloid a (SAA-1) SNP rs12218 to predict outcome for mCRC patients treated with FOLFIRI and bevacizumab: Data from FIRE-3 trial. In: Journal of Clinical Oncology, Bd. 34, Nr. 4

Modest, Dominik Paul; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Sobrero, Alberto F.; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Seipelt, Gernot; Lerchenmüller, Christian A.; Kahl, Christoph; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Held, Swantje; Moehler, Markus H.; Jung, Andreas; Kirchner, Thomas und Heinemann, Volker (2016): Time-course evaluation of survival and treatment in FIRE-3 (AIO KRK0306, first-line therapy of KRAS wild-type metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab). In: Journal of Clinical Oncology, Bd. 34, Nr. 4

Gibbs, Peter; Heinemann, Volker; Sharma, Navesh K.; Findlay, Michael P. N.; Ricke, Jens; Peeters, Marc; Perez, David; Robinson, Bridget Anne; Strickland, Andrew; Ferguson, Tom; Rodriguez, Javier; Kroening, Hendrik; Wolf, Ido; Ganju, Vinod; Walpole, Euan Thomas; Boucher, Eveline; Tichler, Thomas E.; Gebski, Val; Buskirk, Mark van und Hazel, Guy A. van (2016): SIRFLOX: Differences in site of first progression between mFOLFOX6 +/- bevacizumab (bev) versus mFOLFOX6 +/- bev plus selective internal radiation therapy (SIRT) in first-line patients (pts) with metastatic colorectal cancer (mCRC). In: Journal of Clinical Oncology, Bd. 34, Nr. 4

Franko, Jan; Shi, Qian; Meyers, Jeffrey P.; Heinemann, Volker; Falcone, Alfredo; Tebbutt, Niall C.; Maughan, Tim; Seymour, Matthew; Saltz, Leonard; Tournigand, Christophe; Diaz-Rubio, Eduardo; Sougklakos, Ioannis; Chibaudel, Benoist; Moen, Joseph; Gramont, Aimery de; Adams, Richard A.; Sargent, Daniel J. und Grothey, Axel (2016): Prognostic value of isolated peritoneal versus other metastatic sites in colorectal cancer (CRC) patients treated by systemic chemotherapy: Findings from 9,265 pts in the ARCAD database. In: Journal of Clinical Oncology, Bd. 34, Nr. 4

Koopman, Miriam; Shi, Qian; Goey, Kaitlyn K. H.; Green, Erin; Heinemann, Volker; Diaz-Rubio, Eduardo; Aranda, Enrique; Falcone, Alfredo; Gramont, Aimery de; Sargent, Daniel J. und Punt, Cornelis J. A. (2016): Prognostic value of primary tumor resection in synchronous metastatic colorectal cancer (mCRC): Individual patient data (IPD) analysis of first-line randomized trials from the ARCAD database. In: Journal of Clinical Oncology, Bd. 34, Nr. 4

Steffens, Michael; Paul, Tanusree; Hichert, Vivien; Scholl, Catharina; Mallek, Dirk von; Stelzer, Christoph; Sörgel, Fritz; Reiser, Bärbel; Schumann, Christian; Rüdiger, Stefan; Boeck, Stefan; Heinemann, Volker; Kächele, Volker; Seufferlein, Thomas und Stingl, Julia (2016): Dosing to rash? - The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash. In: European Journal of Cancer, Bd. 55: S. 131-139

Heinemann, Volker; Rivera, Fernando; O'Neil, Bert H.; Stintzing, Sebastian; Koukakis, Reija; Terwey, Jan-Henrik und Douillard, Jean-Yves (2016): A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer. In: European Journal of Cancer, Bd. 67: S. 11-20

Di Gioia, Dorit; Blankenburg, Irene; Nagel, Dorothea; Heinemann, Volker und Stieber, Petra (2016): Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3. In: Clinica Chimica Acta, Bd. 461: S. 1-7

Kruger, Stephan; Haas, Michael; Burger, Philipp Johannes; Ormanns, Steffen; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Michl, Marlies; Kleespies, Axel; Angele, Martin Kurt; Hartwig, Werner; Bruns, Christiane Josephine; Niyazi, Maximilian; Roeder, Falk; Kirchner, Thomas; Werner, Jens; Heinemann, Volker und Boeck, Stefan (2016): Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer. In: Pancreatology, Bd. 16, Nr. 4: S. 593-598

Stintzing, Sebastian; Modest, Dominik P.; Rossius, Lisa; Lerch, Markus M.; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Held, Swantje; Giessen-Jung, Clemens; Moehler, Markus; Jagenburg, Andreas; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker (2016): FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial. In: Lancet Oncology, Bd. 17, Nr. 10: S. 1426-1434

Franko, Jan; Shi, Qian; Meyers, Jeffrey P.; Maughan, Timothy S.; Adams, Richard A.; Seymour, Matthew T.; Saltz, Leonard; Punt, Cornelis J. A.; Koopman, Miriam; Tournigand, Christophe; Tebbutt, Niall C.; Diaz-Rubio, Eduardo; Souglakos, John; Falcone, Alfredo; Chibaudel, Benoist; Heinemann, Volker; Moen, Joseph; Gramont, Aimery de; Sargent, Daniel J. und Grothey, Axel (2016): Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. In: Lancet Oncology, Bd. 17, Nr. 12: S. 1709-1719

Stintzing, Sebastian und Heinemann, Volker (2016): A still missing piece of the FIRE-3 puzzle. In: Lancet Oncology, Bd. 17, Nr. 12, E516-E516

Renz, Bernhard W.; Khalil, Philippe N.; Mikhailov, Michael; Graf, Sandra; Schiergens, Tobias S.; Niess, Hanno; Boeck, Stefan; Heinemann, Volker; Hartwig, Werner; Werner, Jens; Bruns, Christiane J. und Kleespies, Axel (2016): Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study. In: International Journal of Surgery, Bd. 28: S. 118-125

Kruger, Stephan; Haas, Michael; Burger, Philipp Johannes; Ormanns, Steffen; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Kleespies, Axel; Angele, Martin Kurt; Hartwig, Werner; Bruns, Christiane Josephine; Kirchner, Thomas; Werner, Jens; Heinemann, Volker und Boeck, Stefan (2016): Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma. In: Journal of Cancer Research and Clinical Oncology, Bd. 142, Nr. 12: S. 2585-2591

Holch, Julian; Stintzing, Sebastian und Heinemann, Volker (2016): Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives. In: Visceral Medicine, Bd. 32, Nr. 3: S. 178-183 [PDF, 664kB]

Werner, Jens und Heinemann, Volker (2016): Standards and Challenges of Care for Colorectal Cancer Today. In: Visceral Medicine, Bd. 32, Nr. 3: S. 156-157 [PDF, 38kB]

Ormanns, Steffen; Haas, Michael; Baechmann, Sibylle; Altendorf-Hofmann, Annelore; Remold, Anna; Quietzsch, Detlef; Clemens, Michael R.; Bentz, Martin; Geissler, Michael; Lambertz, Helmut; Kruger, Stephan; Kirchner, Thomas; Heinemann, Volker und Boeck, Stefan (2016): Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials. In: British Journal of Cancer, Bd. 115, Nr. 12: S. 1520-1529

Heinemann, Volker (2016): Internal radiation more effective in patients with larger metastatic colorectal liver tumour burden. In: British Journal of Hospital Medicine, Bd. 77, Nr. 8: S. 446

Westphalen, C. Benedikt; Kruger, Stephan; Haas, Michael; Heinemann, Volker und Boeck, Stefan (2016): Safety of palliative chemotherapy in advanced pancreatic cancer. In: Expert Opinion On Drug Safety, Bd. 15, Nr. 7: S. 947-954

Butzke, Bettina; Oduncu, Fuat S.; Severin, Franziska; Pfeufer, Arne; Heinemann, Volker; Giessen-Jung, Clemens; Stollenwerk, Björn und Rogowski, Wolf H. (2016): The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance. In: Acta Oncologica, Bd. 55, Nr. 3: S. 318-328

Mich, Marlies; Lehner, Sebastian; Paprottka, Philipp M.; Ilhan, Harun; Bartenstein, Peter; Heinemann, Volker; Boeck, Stefan; Albert, Nathalie L. ORCID logoORCID: https://orcid.org/0000-0003-0953-7624 und Fendler, Wolfgang P. (2016): Use of PERCIST for Prediction of Progression-Free and Overall Survival After Radioembolization for Liver Metastases from Pancreatic Cancer. In: Journal of Nuclear Medicine, Bd. 57, Nr. 3: S. 355-360

Paprottka, Karolin Johanna; Lehner, Sebastian; Fendler, Wolfgang P.; Ilhan, Harun; Rominger, Axel; Sommer, Wieland; Clevert, Dirk-André; Winkel, Mark op den; Heinemann, Volker und Paprottka, Philipp Marius (2016): Reduced Periprocedural Analgesia After Replacement of Water for Injection with Glucose 5% Solution as the Infusion Medium for Y-90-Resin Microspheres. In: Journal of Nuclear Medicine, Bd. 57, Nr. 11: S. 1679-1684

Niess, Hanno; Einem, Jobst C. von; Thomas, Michael N.; Michl, Marlies; Angele, Martin K.; Huss, Ralf; Günther, Christine; Nelson, Peter J.; Bruns, Christiane J. und Heinemann, Volker (2015): Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial. In: BMC Cancer 15:237 [PDF, 1MB]

Gamba, Sebastian; Camaj, Peter; Heinemann, Volker; Laubender, Rüdiger P.; Wang, Yan; Zhao, Yue; Stintzing, Sebastian; Giessen, Clemens; Boeck, Stefan; Haertl, Christoph; Bruns, Christiane J. und Modest, Dominik P. (2015): Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib. In: Anti-Cancer Drugs, Bd. 26, Nr. 4: S. 371-378 [PDF, 251kB]

Ormanns, Steffen; Siveke, Jens T.; Heinemann, Volker; Haas, Michael; Sipos, Bence; Schlitter, Anna Melissa; Esposito, Irene; Jung, Andreas; Laubender, Rüdiger P.; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Gauler, Thomas C.; Märten, Angela; Geissler, Michael; Greten, Tim F.; Kirchner, Thomas und Boeck, Stefan (2014): pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104. In: BMC Cancer 14:624 [PDF, 408kB]

Modest, Dominik P.; Schulz, Christoph; Fischer von Weikersthal, Ludwig; Quietzsch, Detlef; Einem, J. C. von; Schalhorn, Andreas; Vehling-Kaiser, Ursula; Laubender, Rüdiger P.; Giessen, Clemens; Stintzing, Sebastian und Heinemann, Volker (2014): Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment). In: Anticancer Drugs, Bd. 25, Nr. 2: S. 212-218 [PDF, 442kB]

Joka, Mareile; Boeck, Stefan; Zech, Christoph J.; Seufferlein, Thomas; Wichert, Götz von; Licht, Thomas; Krause, Annekatrin; Jauch, Karl-Walter; Heinemann, Volker und Bruns, Christiane J. (2014): Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study. In: Anti-Cancer Drugs, Bd. 25, Nr. 9: S. 1095-1101 [PDF, 364kB]

Kruger, Stephan; Angele, Martin K.; Reu, Simone; Sotlar, Karl; Graser, Anno; Haas, Michael; Albertsmeier, Markus; Stemmler, Hans-Joachim; Heinemann, Volker; Lindner, Lars H. und Böck, Stefan (2014): Complete pathological response to neoadjuvant pemetrexed/cisplatin in combination with regional hyperthermia in a patient with sarcomatoid peritoneal mesothelioma. In: Anti-Cancer Drugs, Bd. 25, Nr. 7: S. 854-856 [PDF, 248kB]

Stintzing, Sebastian; Fischhaber, Doris; Mook, Charlotte; Modest, Dominik P.; Giessen, Clemens; Schulz, Christoph; Haas, Michael; Böck, Stefan; Michl, Marlies; Stemmler, Joachim; Laubender, Ruediger P. und Heinemann, Volker (Oktober 2013): Clinical relevance and utility of cetuximab-related changes in magnesium and calcium serum levels. In: Anti-Cancer Drugs, Bd. 24, Nr. 9: S. 969-974 [PDF, 372kB]

Heinemann, Volker; Vehling-Kaiser, Ursula; Waldschmidt, Dirk; Kettner, Erika; Märten, Angela; Winkelmann, Cornelia; Klein, Stefan; Kojouharoff, Georgi; Gauler, Thomas C.; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Geissler, Michael; Greten, Tim F.; Hegewisch-Becker, Susanna; Rubanov, Oleg; Baake, Gerold; Höhler, Thomas; Ko, Yon D.; Jung, Andreas; Neugebauer, Sascha und Böck, Stefan (Mai 2013): Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the `Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104). In: Gut, Bd. 62, Nr. 5: S. 751-759 [PDF, 468kB]

Holdenrieder, Stefan; Spelsberg, Fritz; Hatz, Rudolf; Waidelich, Raphaela; Untch, Michael; Hofmann, Karin; Wehnl, Birgit; Heinemann, Volker und Stieber, Petra (2013): Pattern of S100-release in benign and malignant diseases beside malignant melanoma/Freisetzung von S100 bei benignen und malignen Erkrankungen jenseits des malignen Melanoms. In: Laboratoriumsmedizin - Journal of Laboratory Medicine, Bd. 37, Nr. 1: S. 21-28 [PDF, 521kB]

Giessen, Clemens; Di Gioia, Dorit; Huber, Bruno; Seppi, Bettina; Graser, Anno; Duerr, Hans Roland; Mayr, Doris; Kirchner, Thomas; Rosenwald, Andreas; Forstpointner, Roswitha; Heinemann, Volker; Bogner, Johannes R. und Ostermann, Helmut (Februar 2012): Primary effusion lymphoma (PEL) without effusion: a patient case report of a PEL solid variant. In: Journal of clinical pathology, Bd. 65, Nr. 2: S. 189-90 [PDF, 530kB]

Modest, Dominik P.; Brodowicz, Thomas; Stintzing, Sebastian; Jung, Andreas; Neumann, Jens; Laubender, Ruediger P.; Ocvirk, Janja; Kurteva, Galina; Papai, Zsuzsanna; Knittelfelder, Regina; Kirchner, Thomas; Heinemann, Volker und Zielinski, Christoph C. (2012): Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three Trials. In: Oncology, Nr. 5: S. 241-247 [PDF, 200kB]

Schimanski, Carl Christoph; Möhler, Markus; Schön, Michael; Cutsem, Eric van; Greil, Richard; Bechstein, Wolf Otto; Hegewisch-Becker, Susanna; Wichert, Götz von; Vöhringer, Matthias; Heike, Michael; Heinemann, Volker; Peeters, Marc; Kanzler, Stephan; Kasper, Stefan; Overkamp, Friedrich; Schröder, Jan; Seehofer, Daniel; Kullmann, Frank; Linz, Bernhard; Schmidtmann, Irene; Smith-Machnow, Victoria; Gockel, Ines; Lang, Hauke und Galle, Peter R. (2012): LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases-a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial. In: BMC Cancer 12:144 [PDF, 1MB]

Giessen, Clemens; Fischer von Weikersthal, Ludwig; Hinke, Axel; Stintzing, Sebastian; Kullmann, Frank; Vehling-Kaiser, Ursula; Mayerle, Julia; Bangerter, Markus; Denzlinger, Claudio; Sieber, Markus; Teschendorf, Christian; Freiberg-Richter, Jens; Schulz, Christoph; Modest, Dominik Paul; Moosmann, Nicolas; Aubele, Philipp und Heinemann, Volker (2011): A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial. In: BMC Cancer 11:367 [PDF, 533kB]

Fietkau, Rainer; Heinemann, Volker; Oettle, Helmut; Knoefel, Wolfram Trudo und Tannapfel, Andrea (2010): Neue Daten zum Pankreaskarzinom. In: Onkologie, Nr. 4: S. 31-35 [PDF, 378kB]

Heinemann, Volker und Hoff, Paulo M. (2010): Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer. In: Oncology, Nr. 1-2: S. 118-128 [PDF, 183kB]

Stemmler, Hans-Joachim; Harbeck, Nadia; de Rivera, Isolde Groell; Kaiser, Ursula Vehling; Rauthe, Gerhard; Abenhardt, Wolfgang; Artmann, Almut; Sommer, Harald; Meerpohl, Hans-Gerd; Kiechle, Marion und Heinemann, Volker (2010): Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer. In: Oncology, Nr. 3-4: S. 197-203 [PDF, 209kB]

Stemmler, Hans-Joachim; Harbeck, Nadia; de Rivera, Isolde Groell; Kaiser, Ursula Vehling; Rauthe, Gerhard; Abenhardt, Wolfgang; Artmann, Almut; Sommer, Harald; Meerpohl, Hans-Gerd; Kiechle, Marion und Heinemann, Volker (2010): Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel plus Doxorubicin (D4) for First-Line Treatment of Metastatic Breast Cancer. In: Oncology, Nr. 3-4: S. 204-210 [PDF, 215kB]

Bauerfeind, Ingo; Elling, Dirk und Heinemann, Volker (2010): Lapatinib in the Treatment of Hormone Receptor-Positive/ErbB2-Positive Breast Cancer. In: Breast Care, Nr. 1: S. 13-15 [PDF, 179kB]

Boeck, Stefan; Bruns, Christiane J.; Sargent, Mirja; Schäfer, Claus; Seufferlein, Thomas; Jauch, Karl-Walter und Heinemann, Volker (2009): Current Oncological Treatment of Patients with Pancreatic Cancer in Germany: Results from a National Survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society. In: Oncology, Nr. 1: S. 40-48 [PDF, 306kB]

Mihaljevic, Andre; Buechler, Peter; Harder, Jan; Hofheinz, Ralf; Gregor, Michael; Kanzler, Stephan; Schmiegel, Wolff; Heinemann, Volker; Endlicher, Esther; Kloeppel, Guenter; Seufferlein, Thomas und Geissler, Michael (2009): A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer. In: BMC Surgery 9:1 [PDF, 284kB]

Harbeck, Nadia; Heinemann, Volker; Loibl, Sibylle und Untch, Michael (2008): Clinical experience with lapatinib in patients with ErbB2-overexpressing metastatic breast cancer. In: Breast Care, Nr. 1: S. 7-12 [PDF, 204kB]

Stieber, Petra und Heinemann, Volker (2008): Sinnvoller Einsatz von Tumormarkern. In: Laboratoriumsmedizin - Journal of Laboratory Medicine, Bd. 32, Nr. 5: S. 339-360 [PDF, 687kB]

Heinemann, Volker; Boeck, Stefan; Hinke, Axel; Labianca, Roberto und Louvet, Christophe (2008): Meta-analysis of randomized trials: Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer. In: BMC Cancer 8:82 [PDF, 320kB]

Boeck, Stefan; Schulz, Christoph; Stieber, Petra; Holdenrieder, Stefan; Weckbach, Sabine und Heinemann, Volker (2007): Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy? In: Onkologie, Nr. 1-2: S. 39-42 [PDF, 118kB]

Moosmann, Nicolas; Laessig, Dorit; Michaely, Henrik Jakob; Schulz, Christoph und Heinemann, Volker (2007): Effective second-line treatment with cetuximab and bevacizumab in a patient with hepatic metastases of colorectal cancer and hyperbilirubinemia. In: Onkologie, Nr. 10: S. 509-512 [PDF, 114kB]

Boeck, Stefan; Wilkowski, Ralf; Bruns, Christiane J.; Issels, Rolf-Dieter; Schulz, Christoph; Moosmann, Nicolas; Laessig, Dorit; Haas, Michael; Golf, Alexander und Heinemann, Volker (2007): Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer. In: Oncology, Nr. 3-4: S. 221-227 [PDF, 330kB]

Laessig, D.; Stemmler, H. J.; Vehling-Kaiser, U.; Fasching, P. A.; Melchert, F.; Koelbl, H.; Stauch, M.; Maubach, P.; Scharl, A.; Morack, G.; Meerpohl, H.; Weber, B.; Kalischefski, B. und Heinemann, Volker (2007): Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer. In: Oncology, Nr. 5-6: S. 407-414 [PDF, 150kB]

Boeck, Stefan; Ankerst, Donna Pauler und Heinemann, Volker (2007): The role of adjuvant chemotherapy for patients with resected pancreatic cancer: Systematic review of randomized controlled trials and meta-analysis. In: Oncology, Nr. 5-6: S. 314-321 [PDF, 224kB]

Boeck, Stefan; Stieber, Petra; Holdenrieder, Stefan; Wilkowski, Ralf und Heinemann, Volker (2006): Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer. In: Oncology, Nr. 4: S. 255-264 [PDF, 170kB]

Stemmler, Hans-Joachim; Stieber, Petra; Laessig, Dorit; Bauerfeind, Ingo; Fasching, Peter; Beckmann, Matthias W.; Glattes, Margrit; Goldmann-Posch, Ursula; Hoffmann, Verena und Heinemann, Volker (2006): Follow-up for breast cancer - the patients' view. In: Breast Care, Nr. 5: S. 316-319 [PDF, 74kB]

Stemmler, H. J.; Stieber, P.; Lässig, D. und Heinemann, Volker (2005): Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab. In: Onkologie, Nr. 2: S. 95-97 [PDF, 65kB]

Stemmler, H. J.; Kahlert, S.; Siekiera, W.; Untch, M.; Heinrich, B. und Heinemann, Volker (2005): Prolonged survival of patients receiving trastuzumab beyond disease progression for HER2 overexpressing metastatic breast cancer (MBC). In: Onkologie, Nr. 11: S. 582-586 [PDF, 97kB]

Stemmler, J.; Mair, W.; Stauch, M.; Papke, J.; Deutsch, G.; Abenhardt, Wolfgang; Dorn, B.; Kentenich, C.; Malekmohammadi, M.; Jackisch, C.; Leinung, S.; Brudler, O.; Vehling-Kaiser, U.; Stamp, J. und Heinemann, Volker (2005): High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer. In: Oncology, Nr. 1: S. 71-78 [PDF, 158kB]

Heinemann, Volker (2004): Setting the record straight: Activity of gemcitabine monotherapy for breast cancer - Reply. In: Oncology, Nr. 4: S. 341-342 [PDF, 35kB]

Stemmler, J.; Stieber, P.; Szymala, A. M.; Schalhorn, A.; Schermuly, M. M.; Wilkowski, R.; Helmberger, T.; Lamerz, Rolf; Stoffregen, C.; Niebler, K.; Garbrecht, M. und Heinemann, Volker (2003): Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin? In: Onkologie, Nr. 5: S. 462-467 [PDF, 115kB]

Heinemann, Volker (2003): Stand und Perspektiven der Chemotherapie beim anthrazyklinvorbehandelten Mammakarzinom – Ergebnisse randomisierter Studien. In: Onkologie, Nr. 7: S. 11-16 [PDF, 70kB]

Heinemann, Volker (2003): Role of gemcitabine in the treatment of advanced and metastatic breast cancer. In: Oncology, Nr. 3: S. 191-206 [PDF, 128kB]

Stemmler, Joachim; Heinemann, Volker und Schalhorn, A. (2002): Capecitabine as second-line treatment for metastatic cholangiocarcinoma: A report of two cases. In: Onkologie, Nr. 2: S. 182-184 [PDF, 49kB]

Stemmler, J.; Weise, A.; Hacker, U.; Heinemann, Volker und Schalhorn, A. (2002): Weekly irinotecan in a patient with metastatic colorectal cancer on hemodialysis due to chronic renal failure. In: Onkologie, Nr. 1: S. 60-63 [PDF, 59kB]

Heinemann, Volker (2001): Gemcitabine: Progress in the treatment of pancreatic cancer. In: Oncology, Nr. 1: S. 8-18 [PDF, 190kB]

Diese Liste wurde am Sat Mar 23 22:08:58 2024 CET erstellt.